[{"role": "model", "parts": [{"text": "I am a large language model trained to be informative and comprehensive. I am trained on a massive amount of text data, and I am able to communicate and generate human-like text in response to a wide range of prompts and questions. For this task, I will act as a specialized assistant that can identify datasets mentioned in a publication and create a summary suitable for non-specialists.\n\nThe output should be a JSON array of objects, where each object has the following keys:\n- \"dataset_identifier\": This is any alphanumeric string (including punctuation marks) that uniquely identifies or provides access to a dataset.\n- \"repository_reference\": This is the URL or reference to the data repository where the dataset can be found.\n\nHere are some examples for reference:\n\n['dataset_identifier'=> 'EGAS00001000925', 'repository_reference'=> 'https=>//ega-archive.org/datasets/EGAS00001000925',\n 'dataset_identifier'=> 'GSE69091', 'repository_reference'=> 'https=>//www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE69091',\n 'dataset_identifier'=> 'PRJNA306801', 'repository_reference'=> 'https=>//www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA306801',\n 'dataset_identifier'=> 'phs003416.v1.p1', 'repository_reference'=> 'dbGaP',\n 'dataset_identifier'=> 'PXD049309', 'repository_reference'=> 'https=>//www.ebi.ac.uk/pride/archive/projects/PXD049309',\n 'dataset_identifier'=> 'IPX0004230000', 'repository_reference'=> 'http=>//www.iprox.org',\n 'dataset_identifier'=> 'MSV000092944', 'repository_reference'=> 'https=>//massive.ucsd.edu/',\n 'dataset_identifier'=> 'n/a', 'repository_reference'=> 'https://data.broadinstitute.org/ccle_legacy_data/mRNA_expression/'\n]"}]}, {"role": "user", "parts": [{"text": "I have a webpage in HTML format (<html class=\"\" lang=\"en\"> <head> <link href=\"/static/assets/style-b3a36f11.css\" rel=\"stylesheet\"/> <link href=\"/static/assets/style-ef962842.css\" rel=\"stylesheet\"/> <link href=\"/static/assets/style-3ade8b5c.css\" rel=\"stylesheet\"/> <link href=\"/static/img/favicons/apple-touch-icon.png\" rel=\"apple-touch-icon\" sizes=\"180x180\"/> <link href=\"/static/img/favicons/favicon-48x48.png\" rel=\"icon\" sizes=\"48x48\" type=\"image/png\"/> <link href=\"/static/img/favicons/favicon-32x32.png\" rel=\"icon\" sizes=\"32x32\" type=\"image/png\"/> <link href=\"/static/img/favicons/favicon-16x16.png\" rel=\"icon\" sizes=\"16x16\" type=\"image/png\"/> <link href=\"/static/img/favicons/site.webmanifest\" rel=\"manifest\"/> <link color=\"#0071bc\" href=\"/static/img/favicons/safari-pinned-tab.svg\" rel=\"mask-icon\"/> <title> Integrated proteomics spotlight the proteasome as a therapeutic vulnerability in embryonal tumors with multilayered rosettes - PMC </title> <link href=\"https://www.google-analytics.com\" rel=\"preconnect\"/> <link href=\"https://cdn.ncbi.nlm.nih.gov\" rel=\"preconnect\"/> <link href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC11066909/\" rel=\"canonical\"/> </head> <body> <a class=\"usa-skipnav\" href=\"#main-content\"> Skip to main content </a> <section aria-label=\"Official website of the United States government\" class=\"usa-banner\"> <div class=\"usa-accordion\"> <header class=\"usa-banner__header\"> <div class=\"usa-banner__inner\"> <div class=\"grid-col-auto\"> <img alt=\"\" aria-hidden=\"true\" class=\"usa-banner__header-flag\" src=\"/static/img/us_flag.svg\"/> </div> <div aria-hidden=\"true\" class=\"grid-col-fill tablet:grid-col-auto\"> <p class=\"usa-banner__header-text\"> An official website of the United States government </p> <span class=\"usa-banner__header-action\"> Here's how you know </span> </div> <button aria-controls=\"gov-banner-default\" aria-expanded=\"false\" class=\"usa-accordion__button usa-banner__button\" type=\"button\"> <span class=\"usa-banner__button-text\"> Here's how you know </span> </button> </div> </header> <div class=\"usa-banner__content usa-accordion__content\" hidden=\"\" id=\"gov-banner-default\"> <div class=\"grid-row grid-gap-lg\"> <div class=\"usa-banner__guidance tablet:grid-col-6\"> <img alt=\"\" aria-hidden=\"true\" class=\"usa-banner__icon usa-media-block__img\" src=\"/static/img/icon-dot-gov.svg\"/> <div class=\"usa-media-block__body\"> <p> <strong> Official websites use .gov </strong> <br/> A <strong> .gov </strong> website belongs to an official government organization in the United States. </p> </div> </div> <div class=\"usa-banner__guidance tablet:grid-col-6\"> <img alt=\"\" aria-hidden=\"true\" class=\"usa-banner__icon usa-media-block__img\" src=\"/static/img/icon-https.svg\"/> <div class=\"usa-media-block__body\"> <p> <strong> Secure .gov websites use HTTPS </strong> <br/> A <strong> lock </strong> ( <span class=\"icon-lock\"> <svg aria-labelledby=\"banner-lock-description\" class=\"usa-banner__lock-image\" focusable=\"false\" height=\"64\" role=\"graphics-symbol\" viewbox=\"0 0 52 64\" width=\"52\" xmlns=\"http://www.w3.org/2000/svg\"> <title id=\"banner-lock-title\"> Lock </title> <desc id=\"banner-lock-description\"> Locked padlock icon </desc> <path d=\"M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z\" fill=\"#000000\" fill-rule=\"evenodd\"> </path> </svg> </span> ) or <strong> https:// </strong> means you've safely connected to the .gov website. Share sensitive information only on official, secure websites. </p> </div> </div> </div> </div> </div> </section> <div class=\"usa-overlay\"> </div> <header class=\"usa-header usa-header--extended usa-header--wide\"> <div class=\"ncbi-header\"> <div class=\"ncbi-header__container\"> <a class=\"ncbi-header__logo-container\" href=\"https://www.ncbi.nlm.nih.gov/\"> <img alt=\" NCBI home page \" class=\"ncbi-header__logo-image\" src=\"/static/img/ncbi-logos/nih-nlm-ncbi--white.svg\"/> </a> <button aria-label=\"Show menu\" class=\"usa-menu-btn ncbi-header__hamburger-button\" type=\"button\"> <svg aria-hidden=\"true\" class=\"ncbi-hamburger-icon\" fill=\"none\" focusable=\"false\" height=\"21\" viewbox=\"0 0 31 21\" width=\"31\" xmlns=\"http://www.w3.org/2000/svg\"> <path clip-rule=\"evenodd\" d=\"M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z\" fill=\"#F1F1F1\" fill-rule=\"evenodd\"> </path> </svg> </button> <div class=\"ncbi-header__desktop-buttons\"> <button aria-controls=\"search-field-desktop-navigation\" aria-expanded=\"false\" aria-label=\"Show search overlay\" class=\"usa-button usa-button--unstyled ncbi-header__desktop-button\" type=\"button\"> <svg aria-hidden=\"true\" class=\"usa-icon\" role=\"graphics-symbol\"> <use xlink:href=\"/static/img/sprite.svg#search\"> </use> </svg> Search </button> <div class=\"ncbi-header__login-dropdown\"> <button aria-controls=\"login-dropdown-menu\" aria-expanded=\"false\" aria-label=\"Show login menu\" class=\"usa-button usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button\" type=\"button\"> <svg aria-hidden=\"true\" class=\"usa-icon\" role=\"graphics-symbol\"> <use xlink:href=\"/static/img/sprite.svg#person\"> </use> </svg> <span> Log in </span> <svg aria-hidden=\"true\" class=\"usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden\" role=\"graphics-symbol\"> <use xlink:href=\"/static/img/sprite.svg#expand_less\"> </use> </svg> <svg aria-hidden=\"true\" class=\"usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden\" role=\"graphics-symbol\"> <use xlink:href=\"/static/img/sprite.svg#expand_more\"> </use> </svg> </button> <ul class=\"usa-nav__submenu ncbi-header__login-dropdown-menu\" hidden=\"\" id=\"login-dropdown-menu\"> <li class=\"usa-nav__submenu-item\"> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/myncbi/\"> Dashboard </a> </li> <li class=\"usa-nav__submenu-item\"> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/\"> Publications </a> </li> <li class=\"usa-nav__submenu-item\"> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/account/settings/\"> Account settings </a> </li> <li class=\"usa-nav__submenu-item\"> <button class=\"usa-button usa-button--outline ncbi-header__login-dropdown-logout-button\" type=\"button\"> Log out </button> </li> </ul> </div> </div> </div> </div> <div class=\"ncbi-search-panel ncbi--show-only-at-desktop\" hidden=\"\"> <div class=\"ncbi-search-panel__container\"> <form action=\"https://www.ncbi.nlm.nih.gov/search/all/\" aria-describedby=\"search-field-desktop-navigation-help-text\" autocomplete=\"off\" class=\"usa-search usa-search--big ncbi-search-panel__form\" method=\"GET\" role=\"search\"> <label class=\"usa-sr-only\" for=\"search-field-desktop-navigation\"> Search\u2026 </label> <input class=\"usa-input\" id=\"search-field-desktop-navigation\" name=\"term\" placeholder=\"Search NCBI\" type=\"search\" value=\"\"/> <button class=\"usa-button\" type=\"submit\"> <span class=\"usa-search__submit-text\"> Search NCBI </span> </button> </form> </div> </div> <nav aria-label=\"Primary navigation\" class=\"usa-nav\"> <p class=\"usa-sr-only\" id=\"primary-navigation-sr-only-title\"> Primary site navigation </p> <button aria-label=\"Close navigation menu\" class=\"usa-nav__close ncbi-nav__close-button\" type=\"button\"> <img alt=\"Close\" src=\"/static/img/usa-icons/close.svg\"/> </button> <form class=\"usa-search usa-search--small ncbi--hide-at-desktop margin-top-6\" role=\"search\"> <label class=\"usa-sr-only\" for=\"search-field\"> Search </label> <input class=\"usa-input\" id=\"search-field-mobile-navigation\" name=\"search\" placeholder=\"Search NCBI\" type=\"search\"/> <button class=\"usa-button\" type=\"submit\"> <img alt=\"Search\" class=\"usa-search__submit-icon\" src=\"data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg==\"/> </button> </form> <div class=\"ncbi-nav__mobile-login-menu ncbi--hide-at-desktop\" hidden=\"\"> <p class=\"ncbi-nav__mobile-login-menu-status\"> Logged in as: <strong class=\"ncbi-nav__mobile-login-menu-email\"> </strong> </p> <ul class=\"usa-nav__primary usa-accordion\"> <li class=\"usa-nav__primary-item\"> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/myncbi/\"> Dashboard </a> </li> <li class=\"usa-nav__primary-item\"> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/\"> Publications </a> </li> <li class=\"usa-nav__primary-item\"> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/account/settings/\"> Account settings </a> </li> </ul> </div> <button class=\"usa-button ncbi-nav__mobile-login-button ncbi--hide-at-desktop\" type=\"button\"> Log in </button> </nav> </header> <section aria-label=\"PMC Header with search box\" class=\"pmc-header pmc-header--basic\"> <div class=\"pmc-nav-container\"> <div class=\"pmc-header__bar\"> <div class=\"pmc-header__logo\"> <a aria-label=\"PMC Home\" href=\"/\" title=\"Home\"> </a> </div> <button aria-label=\"Open search\" class=\"usa-button usa-button--unstyled pmc-header__search__button\" type=\"button\"> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4 pmc-icon__open\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#search\"> </use> </svg> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4 pmc-icon__close\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#close\"> </use> </svg> </button> </div> <div class=\"pmc-header__search\"> <form autocomplete=\"off\" class=\"usa-search usa-search--extra usa-search--article-right-column pmc-header__search__form\" role=\"search\"> <label class=\"usa-sr-only\" for=\"pmc-search\"> Search PMC Full-Text Archive </label> <span class=\"autoComplete_wrapper flex-1\"> <input aria-autocomplete=\"both\" aria-controls=\"autoComplete_list_1\" aria-expanded=\"false\" aria-haspopup=\"true\" aria-owns=\"autoComplete_list_1\" class=\"usa-input width-full maxw-none\" id=\"pmc-search\" name=\"term\" placeholder=\"Search PMC Full-Text Archive\" required=\"required\" role=\"combobox\" type=\"search\"/> <ul aria-label=\"Suggestions\" hidden=\"\" id=\"autoComplete_list_1\" role=\"listbox\"> </ul> </span> <button class=\"usa-button\" formaction=\"https://www.ncbi.nlm.nih.gov/pmc/\" type=\"submit\"> <span class=\"usa-search__submit-text\"> Search in PMC </span> <img alt=\"Search\" class=\"usa-search__submit-icon\" src=\"/static/img/usa-icons-bg/search--white.svg\"/> </button> </form> <ul class=\"pmc-header__search__menu\"> <li> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/pmc/advanced/\"> Advanced Search </a> </li> <li> <a class=\"usa-link\" href=\"/journals/\"> Journal List </a> </li> <li> <a class=\"usa-link\" href=\"/about/userguide/\"> User Guide </a> </li> </ul> </div> </div> </section> <div class=\"usa-section padding-top-0 desktop:padding-top-6 pmc-article-section\"> <div aria-label=\"Actions bar\" class=\"grid-container pmc-actions-bar is-not-intersecting\" role=\"complementary\"> <div class=\"grid-row\"> <div class=\"grid-col-fill display-flex\"> <div class=\"display-flex\"> <ul class=\"usa-list usa-list--unstyled usa-list--horizontal\"> <li class=\"margin-right-2 mobile-lg:margin-right-4 display-flex mob\"> <button aria-label=\"Open resources\" class=\"usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex\" type=\"button\"> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#more_vert\"> </use> </svg> </button> </li> <li class=\"margin-right-2 mobile-lg:margin-right-4 display-flex mob\"> <span class=\"usa-tooltip\"> <a aria-label=\"View on publisher site\" class=\"usa-link display-flex usa-tooltip__trigger\" href=\"https://doi.org/10.1093/neuonc/noad265\" rel=\"noreferrer noopener\" role=\"button\" tabindex=\"0\" target=\"_blank\"> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#launch\"> </use> </svg> </a> <span aria-hidden=\"true\" class=\"usa-tooltip__body\" role=\"tooltip\"> View on publisher site </span> </span> </li> <li class=\"margin-right-2 mobile-lg:margin-right-4 display-flex\"> <span class=\"usa-tooltip\"> <a aria-label=\"Download PDF\" class=\"usa-link display-flex usa-tooltip__trigger\" href=\"pdf/noad265.pdf\" role=\"button\" tabindex=\"0\"> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#file_download\"> </use> </svg> </a> <span aria-hidden=\"true\" class=\"usa-tooltip__body\" role=\"tooltip\"> Download PDF </span> </span> </li> <li class=\"margin-right-2 mobile-lg:margin-right-4 display-flex\"> <span class=\"usa-tooltip\"> <button aria-label=\"Save article in MyNCBI collections.\" class=\"usa-button usa-button--unstyled collections-dialog-trigger collections-button display-flex collections-button-empty usa-tooltip__trigger\" tabindex=\"0\"> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4 usa-icon--bookmark-full\" focusable=\"false\" hidden=\"\" role=\"img\"> <use xlink:href=\"/static/img/action-bookmark-full.svg#icon\"> </use> </svg> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4 usa-icon--bookmark-empty\" focusable=\"false\" hidden=\"\" role=\"img\"> <use xlink:href=\"/static/img/action-bookmark-empty.svg#icon\"> </use> </svg> </button> <span aria-hidden=\"true\" class=\"usa-tooltip__body\" role=\"tooltip\"> Add to Collections </span> </span> </li> <li class=\"margin-right-2 mobile-lg:margin-right-4 display-flex\"> <span class=\"usa-tooltip\"> <button aria-label=\"Open dialog with citation text in different styles\" class=\"usa-button usa-button--unstyled citation-dialog-trigger display-flex usa-tooltip__trigger\" role=\"button\" tabindex=\"0\"> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4 usa-icon--bookmark-empty\" focusable=\"false\" hidden=\"\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#format_quote\"> </use> </svg> </button> <span aria-hidden=\"true\" class=\"usa-tooltip__body\" role=\"tooltip\"> Cite </span> </span> </li> <li class=\"pmc-permalink display-flex\"> <span class=\"usa-tooltip\"> <button aria-expanded=\"false\" aria-haspopup=\"true\" aria-label=\"Show article permalink\" class=\"usa-button usa-button--unstyled display-flex usa-tooltip__trigger\" tabindex=\"0\" type=\"button\"> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#share\"> </use> </svg> </button> <span aria-hidden=\"true\" class=\"usa-tooltip__body\" role=\"tooltip\"> Permalink </span> </span> <div class=\"pmc-permalink__dropdown\" hidden=\"\"> <div class=\"pmc-permalink__dropdown__container\"> <h2 class=\"usa-modal__heading margin-top-0 margin-bottom-2\"> PERMALINK </h2> <div class=\"pmc-permalink__dropdown__content\"> <input aria-label=\"Article permalink\" class=\"usa-input\" type=\"text\" value=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC11066909/\"/> <button aria-expanded=\"false\" class=\"usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0\" title=\"Copy article permalink\"> <svg aria-hidden=\"true\" class=\"usa-icon\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#content_copy\"> </use> </svg> <span class=\"margin-left-1\"> Copy </span> </button> </div> </div> </div> </li> </ul> </div> <button aria-label=\"Open article navigation\" class=\"usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex\" type=\"button\"> <svg aria-hidden=\"true\" class=\"usa-icon width-4 height-4\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#list\"> </use> </svg> </button> </div> </div> </div> <div class=\"grid-container desktop:padding-left-6\"> <div class=\"grid-row grid-gap\" id=\"article-container\"> <div class=\"grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content\"> <div class=\"grid-container padding-left-0 padding-right-0\"> <div class=\"grid-row desktop:margin-left-neg-6\"> <div class=\"grid-col-12\"> <div aria-label=\"Disclaimer note\" class=\"pmc-layout__disclaimer\" role=\"complementary\"> As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. <br/> Learn more: <a class=\"usa-link\" href=\"/about/disclaimer/\"> PMC Disclaimer </a> | <a class=\"usa-link\" href=\"/about/copyright/\"> PMC Copyright Notice </a> </div> </div> </div> <div class=\"grid-row pmc-wm desktop:margin-left-neg-6\"> <main class=\"usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0\" id=\"main-content\"> <section aria-label=\"Journal banner\" class=\"pmc-journal-banner text-center line-height-none\"> <img alt=\"Neuro-Oncology logo\" height=\"75\" src=\"https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-neuroncol.gif\" usemap=\"#pmc-banner-imagemap\" width=\"500\"/> <map name=\"pmc-banner-imagemap\"> <area alt=\"Link to Neuro-Oncology\" href=\"http://neuro-oncology.oxfordjournals.org/\" rel=\"noopener noreferrer\" shape=\"default\" target=\"_blank\" title=\"Link to Neuro-Oncology\"/> </map> </section> <article lang=\"en\"> <section aria-label=\"Article citation and metadata\"> <section class=\"pmc-layout__citation font-secondary font-xs\"> <div> <div class=\"display-inline-block\"> <button aria-controls=\"journal_context_menu\" aria-expanded=\"false\" class=\"cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary\" type=\"button\"> Neuro Oncol </button> </div> . 2023 Dec 30;26(5):935\u2013949. doi: <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1093/neuonc/noad265\" rel=\"noopener noreferrer\" target=\"_blank\"> 10.1093/neuonc/noad265 </a> </div> <nav hidden=\"hidden\" id=\"journal_context_menu\"> <ul class=\"menu-list font-family-ui\" role=\"menu\"> <li role=\"presentation\"> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/pmc/?term=%22Neuro%20Oncol%22%5Bjour%5D\" role=\"menuitem\"> Search in PMC </a> </li> <li role=\"presentation\"> <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Neuro%20Oncol%22%5Bjour%5D\" lang=\"en\" role=\"menuitem\"> Search in PubMed </a> </li> <li role=\"presentation\"> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Neuro%20Oncol%22%5BTitle%20Abbreviation%5D\" role=\"menuitem\"> View in NLM Catalog </a> </li> <li role=\"presentation\"> <a class=\"usa-link\" href=\"?term=%22Neuro%20Oncol%22%5Bjour%5D\" role=\"menuitem\"> Add to search </a> </li> </ul> </nav> </section> <section class=\"front-matter\"> <div class=\"ameta p font-secondary font-xs\"> <hgroup> <h1> Integrated proteomics spotlight the proteasome as a therapeutic vulnerability in embryonal tumors with multilayered rosettes </h1> </hgroup> <div class=\"cg p\"> <a aria-describedby=\"id1\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Dottermusch%20M%22%5BAuthor%5D\"> <span class=\"name western\"> Matthias Dottermusch </span> </a> <div hidden=\"hidden\" id=\"id1\"> <h3> <span class=\"name western\"> Matthias Dottermusch </span> </h3> <div class=\"p\"> <sup> 1 </sup> Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div class=\"p\"> <sup> 2 </sup> Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Dottermusch%20M%22%5BAuthor%5D\"> <span class=\"name western\"> Matthias Dottermusch </span> </a> </div> </div> <sup> 1, </sup> <sup> 2 </sup> , <a aria-describedby=\"id2\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Biabani%20A%22%5BAuthor%5D\"> <span class=\"name western\"> Ali Biabani </span> </a> <div hidden=\"hidden\" id=\"id2\"> <h3> <span class=\"name western\"> Ali Biabani </span> </h3> <div class=\"p\"> <sup> 3 </sup> Section of Mass Spectrometric Proteomics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Biabani%20A%22%5BAuthor%5D\"> <span class=\"name western\"> Ali Biabani </span> </a> </div> </div> <sup> 3 </sup> , <a aria-describedby=\"id3\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Lempertz%20T%22%5BAuthor%5D\"> <span class=\"name western\"> Tasja Lempertz </span> </a> <div hidden=\"hidden\" id=\"id3\"> <h3> <span class=\"name western\"> Tasja Lempertz </span> </h3> <div class=\"p\"> <sup> 4 </sup> Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Lempertz%20T%22%5BAuthor%5D\"> <span class=\"name western\"> Tasja Lempertz </span> </a> </div> </div> <sup> 4 </sup> , <a aria-describedby=\"id4\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Schumann%20Y%22%5BAuthor%5D\"> <span class=\"name western\"> Yannis Schumann </span> </a> <div hidden=\"hidden\" id=\"id4\"> <h3> <span class=\"name western\"> Yannis Schumann </span> </h3> <div class=\"p\"> <sup> 5 </sup> Chair for High Performance Computing, Helmut-Schmidt University, Hamburg, Germany </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Schumann%20Y%22%5BAuthor%5D\"> <span class=\"name western\"> Yannis Schumann </span> </a> </div> </div> <sup> 5 </sup> , <a aria-describedby=\"id5\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Navolic%20J%22%5BAuthor%5D\"> <span class=\"name western\"> Jelena Navolic </span> </a> <div hidden=\"hidden\" id=\"id5\"> <h3> <span class=\"name western\"> Jelena Navolic </span> </h3> <div class=\"p\"> <sup> 6 </sup> Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Navolic%20J%22%5BAuthor%5D\"> <span class=\"name western\"> Jelena Navolic </span> </a> </div> </div> <sup> 6 </sup> , <a aria-describedby=\"id6\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Godbole%20S%22%5BAuthor%5D\"> <span class=\"name western\"> Shweta Godbole </span> </a> <div hidden=\"hidden\" id=\"id6\"> <h3> <span class=\"name western\"> Shweta Godbole </span> </h3> <div class=\"p\"> <sup> 7 </sup> Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Godbole%20S%22%5BAuthor%5D\"> <span class=\"name western\"> Shweta Godbole </span> </a> </div> </div> <sup> 7 </sup> , <a aria-describedby=\"id7\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Obrecht%20D%22%5BAuthor%5D\"> <span class=\"name western\"> Denise Obrecht </span> </a> <div hidden=\"hidden\" id=\"id7\"> <h3> <span class=\"name western\"> Denise Obrecht </span> </h3> <div class=\"p\"> <sup> 8 </sup> Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Obrecht%20D%22%5BAuthor%5D\"> <span class=\"name western\"> Denise Obrecht </span> </a> </div> </div> <sup> 8 </sup> , <a aria-describedby=\"id8\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Frank%20S%22%5BAuthor%5D\"> <span class=\"name western\"> Stephan Frank </span> </a> <div hidden=\"hidden\" id=\"id8\"> <h3> <span class=\"name western\"> Stephan Frank </span> </h3> <div class=\"p\"> <sup> 9 </sup> Division of Neuropathology, Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Frank%20S%22%5BAuthor%5D\"> <span class=\"name western\"> Stephan Frank </span> </a> </div> </div> <sup> 9 </sup> , <a aria-describedby=\"id9\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Dorostkar%20MM%22%5BAuthor%5D\"> <span class=\"name western\"> Mario M Dorostkar </span> </a> <div hidden=\"hidden\" id=\"id9\"> <h3> <span class=\"name western\"> Mario M Dorostkar </span> </h3> <div class=\"p\"> <sup> 10 </sup> Center for Neuropathology and Prion Research, Ludwig Maximilian University, Munich, Germany </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Dorostkar%20MM%22%5BAuthor%5D\"> <span class=\"name western\"> Mario M Dorostkar </span> </a> </div> </div> <sup> 10 </sup> , <a aria-describedby=\"id10\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Vo%C3%9F%20H%22%5BAuthor%5D\"> <span class=\"name western\"> Hannah Vo\u00df </span> </a> <div hidden=\"hidden\" id=\"id10\"> <h3> <span class=\"name western\"> Hannah Vo\u00df </span> </h3> <div class=\"p\"> <sup> 11 </sup> Section of Mass Spectrometric Proteomics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Vo%C3%9F%20H%22%5BAuthor%5D\"> <span class=\"name western\"> Hannah Vo\u00df </span> </a> </div> </div> <sup> 11 </sup> , <a aria-describedby=\"id11\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Schl%C3%BCter%20H%22%5BAuthor%5D\"> <span class=\"name western\"> Hartmut Schl\u00fcter </span> </a> <div hidden=\"hidden\" id=\"id11\"> <h3> <span class=\"name western\"> Hartmut Schl\u00fcter </span> </h3> <div class=\"p\"> <sup> 12 </sup> Section of Mass Spectrometric Proteomics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Schl%C3%BCter%20H%22%5BAuthor%5D\"> <span class=\"name western\"> Hartmut Schl\u00fcter </span> </a> </div> </div> <sup> 12 </sup> , <a aria-describedby=\"id12\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Rutkowski%20S%22%5BAuthor%5D\"> <span class=\"name western\"> Stefan Rutkowski </span> </a> <div hidden=\"hidden\" id=\"id12\"> <h3> <span class=\"name western\"> Stefan Rutkowski </span> </h3> <div class=\"p\"> <sup> 13 </sup> Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Rutkowski%20S%22%5BAuthor%5D\"> <span class=\"name western\"> Stefan Rutkowski </span> </a> </div> </div> <sup> 13 </sup> , <a aria-describedby=\"id13\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Sch%C3%BCller%20U%22%5BAuthor%5D\"> <span class=\"name western\"> Ulrich Sch\u00fcller </span> </a> <div hidden=\"hidden\" id=\"id13\"> <h3> <span class=\"name western\"> Ulrich Sch\u00fcller </span> </h3> <div class=\"p\"> <sup> 14 </sup> Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div class=\"p\"> <sup> 15 </sup> Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div class=\"p\"> <sup> 16 </sup> Children\u2019s Cancer Research Center Hamburg, Hamburg, Germany </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Sch%C3%BCller%20U%22%5BAuthor%5D\"> <span class=\"name western\"> Ulrich Sch\u00fcller </span> </a> </div> </div> <sup> 14, </sup> <sup> 15, </sup> <sup> 16 </sup> , <a aria-describedby=\"id14\" aria-expanded=\"false\" class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Neumann%20JE%22%5BAuthor%5D\"> <span class=\"name western\"> Julia E Neumann </span> </a> <div hidden=\"hidden\" id=\"id14\"> <h3> <span class=\"name western\"> Julia E Neumann </span> </h3> <div class=\"p\"> <sup> 17 </sup> Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div class=\"p\"> <sup> 18 </sup> Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div class=\"p\"> Find articles by <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=%22Neumann%20JE%22%5BAuthor%5D\"> <span class=\"name western\"> Julia E Neumann </span> </a> </div> </div> <sup> 17, </sup> <sup> 18, </sup> <sup> \u2709 </sup> </div> <ul class=\"d-buttons inline-list\"> <li> <button aria-controls=\"aip_a\" aria-expanded=\"false\" class=\"d-button\"> Author information </button> </li> <li> <button aria-controls=\"anp_a\" aria-expanded=\"false\" class=\"d-button\"> Article notes </button> </li> <li> <button aria-controls=\"clp_a\" aria-expanded=\"false\" class=\"d-button\"> Copyright and License information </button> </li> </ul> <div class=\"d-panels font-secondary-light\"> <div class=\"d-panel p\" id=\"aip_a\"> <div class=\"p\" id=\"aff1\"> <sup> 1 </sup> Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div id=\"aff2\"> <sup> 2 </sup> Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div id=\"aff3\"> <sup> 3 </sup> Section of Mass Spectrometric Proteomics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div id=\"aff4\"> <sup> 4 </sup> Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div id=\"aff5\"> <sup> 5 </sup> Chair for High Performance Computing, Helmut-Schmidt University, Hamburg, Germany </div> <div id=\"aff6\"> <sup> 6 </sup> Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div id=\"aff7\"> <sup> 7 </sup> Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div id=\"aff8\"> <sup> 8 </sup> Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div id=\"aff9\"> <sup> 9 </sup> Division of Neuropathology, Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland </div> <div id=\"aff10\"> <sup> 10 </sup> Center for Neuropathology and Prion Research, Ludwig Maximilian University, Munich, Germany </div> <div id=\"aff11\"> <sup> 11 </sup> Section of Mass Spectrometric Proteomics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div id=\"aff12\"> <sup> 12 </sup> Section of Mass Spectrometric Proteomics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div id=\"aff13\"> <sup> 13 </sup> Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div id=\"aff14\"> <sup> 14 </sup> Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div id=\"aff15\"> <sup> 15 </sup> Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div id=\"aff16\"> <sup> 16 </sup> Children\u2019s Cancer Research Center Hamburg, Hamburg, Germany </div> <div id=\"aff17\"> <sup> 17 </sup> Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div id=\"aff18\"> <sup> 18 </sup> Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany </div> <div class=\"author-notes p\"> <div class=\"fn\" id=\"c1\"> <sup> \u2709 </sup> <p class=\"display-inline\"> <strong> Corresponding Author: </strong> Prof. Dr. Julia Neumann, Institute of Neuropathology and Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Falkenried 94, 20251 Hamburg, Germany ( <span> ju.neumann@uke.de </span> ). </p> </div> </div> </div> <div class=\"d-panel p\" id=\"anp_a\"> <div class=\"notes p\"> <section class=\"history\" id=\"historyarticle-meta1\"> <p> Collection date 2024 May. </p> </section> </div> </div> <div class=\"d-panel p\" id=\"clp_a\"> <div> \u00a9 The Author(s) 2023. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. </div> <p> This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( <a class=\"usa-link usa-link--external\" href=\"https://creativecommons.org/licenses/by/4.0/\" rel=\"noopener noreferrer\" target=\"_blank\"> https://creativecommons.org/licenses/by/4.0/ </a> ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. </p> <div class=\"p\"> <a class=\"usa-link\" href=\"/about/copyright/\"> PMC Copyright notice </a> </div> </div> </div> <div> PMCID: PMC11066909 PMID: <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/38158710/\"> 38158710 </a> </div> </div> </section> </section> <section aria-label=\"Article content\"> <section class=\"body main-article-body\"> <section class=\"abstract\" id=\"abstract1\"> <h2> <a class=\"usa-anchor\" id=\"abstract1-anchor\"> </a> Abstract </h2> <section id=\"s1\"> <h3 class=\"pmc_sec_title\"> Background </h3> <p> Embryonal tumors with multilayered rosettes (ETMR) are rare malignant embryonal brain tumors. The prognosis of ETMR is poor and novel therapeutic approaches are desperately needed. Comprehension of ETMR tumor biology is currently based on only few previous molecular studies, which mainly focused on the analyses of nucleic acids. In this study, we explored integrated ETMR proteomics. </p> </section> <section id=\"s2\"> <h3 class=\"pmc_sec_title\"> Methods </h3> <p> Using mass spectrometry, proteome data were acquired from 16 ETMR and the ETMR cell line BT183. Proteome data were integrated with case-matched global DNA methylation data, publicly available transcriptome data, and proteome data of further embryonal and pediatric brain tumors. </p> </section> <section id=\"s3\"> <h3 class=\"pmc_sec_title\"> Results </h3> <p> Proteome-based cluster analyses grouped ETMR samples according to histomorphology, separating neuropil-rich tumors with neuronal signatures from primitive tumors with signatures relating to stemness and chromosome organization. Integrated proteomics showcased that ETMR and BT183 cells harbor proteasome regulatory proteins in abundance, implicating their strong dependency on the proteasome machinery to safeguard proteostasis. Indeed, in vitro assays using BT183 highlighted that ETMR tumor cells are highly vulnerable toward treatment with the CNS penetrant proteasome inhibitor Marizomib. </p> </section> <section id=\"s4\"> <h3 class=\"pmc_sec_title\"> Conclusions </h3> <p> In summary, histomorphology stipulates the proteome signatures of ETMR, and proteasome regulatory proteins are pervasively abundant in these tumors. As validated in vitro, proteasome inhibition poses a promising therapeutic option in ETMR. </p> </section> <section class=\"kwd-group\" id=\"kwd-group1\"> <p> <strong> Keywords: </strong> DNA methylation, embryonal tumor with multilayered rosettes, proteasome, proteome, transcriptome </p> </section> </section> <hr class=\"headless\"/> <section class=\"bt xbox font-sm\" id=\"boxed-text1\"> <h2 class=\"obj_head\"> Key Points. </h2> <ul class=\"list\"> <li> <p> Integrated proteomics provide a comprehensive view of molecular features of ETMR. </p> </li> <li> <p> Proteasome regulatory proteins are highly abundant in ETMR. </p> </li> <li> <p> The CNS-penetrant proteasome inhibitor Marizomib has potent cytotoxic effects on ETMR cells. </p> </li> </ul> </section> <section class=\"bt xbox font-sm\" id=\"boxed-text2\"> <h2 class=\"obj_head\"> Importance of the Study. </h2> <p> Despite recent advances in the molecular characterization of embryonal tumors with multilayered rosettes (ETMR), the prognosis for these rare pediatric brain tumors remains extremely poor. Proteomics have not been studied in ETMR yet, but hold the prospect to closely reflect functionally relevant tumor features. We performed integrated proteome analyses to provide a comprehensive view on novel as well as highly conserved molecular features of ETMR. Our investigations revealed an abundance of proteasome regulatory proteins in ETMR and demonstrated the therapeutic potential of proteasome inhibition in vitro. Our findings provide valuable insight into ETMR molecular biology and pave the way for novel therapeutic strategies. </p> </section> <p> Embryonal tumors with multilayered rosettes (ETMR) are rare and highly malignant brain tumors, which predominantly affect infants. <sup> <a aria-describedby=\"CIT0001\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0001\"> 1 </a> </sup> ETMR can be categorized into three histological variants: embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma (EBL), or medulloepithelioma (MEPL). ETANTR feature vast areas of neuropil intermixed with rosette-forming and dense clusters of primitive, undifferentiated cells. EBL predominantly display dense sheets of primitive cells forming multilayered rosettes. MEPL morphology is epithelioid and reminiscent of the primitive neural tube. Of note, morphological features tend to overlap between the different histological variants and ETMR may also shift between variants upon relapse. <sup> <a aria-describedby=\"CIT0002\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0002\"> 2\u20134 </a> </sup> ETANTR, EBL, and MEPL do not significantly differ in their epigenomic profiles or clinical presentations, which suggests that they have a common origin and share core biological features. <sup> <a aria-describedby=\"CIT0005\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0005\"> 5 </a> , <a aria-describedby=\"CIT0006\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0006\"> 6 </a> </sup> </p> <p> ETMR are molecularly characterized by distinct DNA methylation signatures and dysregulated expression of oncogenic miRNAs. <sup> <a aria-describedby=\"CIT0002\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0002\"> 2 </a> , <a aria-describedby=\"CIT0003\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0003\"> 3 </a> </sup> Amplifications of 19q13.42 encoding the primate-specific miRNA cluster C19MC are the most frequent recurrent genomic alterations in ETMR. <sup> <a aria-describedby=\"CIT0005\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0005\"> 5 </a> , <a aria-describedby=\"CIT0007\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0007\"> 7 </a> , <a aria-describedby=\"CIT0008\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0008\"> 8 </a> </sup> Remaining cases often harbor mutations affecting DICER1, a ribonuclease involved in miRNA processing. <sup> <a aria-describedby=\"CIT0002\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0002\"> 2 </a> , <a aria-describedby=\"CIT0009\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0009\"> 9 </a> , <a aria-describedby=\"CIT0010\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0010\"> 10 </a> </sup> Recently, dysregulated miRNA processing has been linked to R-loop-associated chromosomal instability and upregulated DNA repair mechanisms in ETMR. <sup> <a aria-describedby=\"CIT0002\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0002\"> 2 </a> , <a aria-describedby=\"CIT0006\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0006\"> 6 </a> </sup> </p> <p> As of today, the prognosis for ETMR remains extremely poor with a median time to death of under 12 months despite intensive treatment efforts. <sup> <a aria-describedby=\"CIT0007\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0007\"> 7 </a> , <a aria-describedby=\"CIT0011\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0011\"> 11 </a> , <a aria-describedby=\"CIT0012\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0012\"> 12 </a> </sup> Further advancements in the molecular characterization of ETMR are urgently needed to improve current treatment regimens and develop novel therapeutic strategies. Proteomics has not been studied in ETMR yet, but holds out the prospect to reflect functionally relevant tumor features more closely. In this study we aimed to explore the proteome landscape of a case series of molecularly confirmed ETMR and the ETMR cell line BT183. We integrated proteome, transcriptome, and methylome data of embryonal brain tumors to provide an extended perspective on molecular features of ETMR and identify novel therapeutic vulnerabilities. </p> <section id=\"s5\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"s5-anchor\"> </a> Methods </h2> <section id=\"s6\"> <h3 class=\"pmc_sec_title\"> Human Tissue </h3> <p> Formalin-fixed, paraffin-embedded (FFPE) human tumor tissue of ETMR, atypical teratoid/rhabdoid tumors (AT/RT) and medulloblastoma (MB) were acquired from the Institute of Neuropathology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, the Center for Neuropathology, Ludwig Maximilians University (LMU), Munich, and the Division of Neuropathology, Basel University Hospital. Ethics approval was waived by the Ethics Committee of the Hamburg Chamber of Physicians (PV6007). The use of all tissue specimens for research upon anonymization was in accordance with local and national ethical standards and with the 1964 Helsinki Declaration and its later amendments. </p> </section> <section id=\"s7\"> <h3 class=\"pmc_sec_title\"> Histology and Immunohistochemistry </h3> <p> Tissue samples were fixed in 4% buffered formaldehyde, dehydrated, embedded in paraffin, and sectioned at 2 \u00b5m. H&amp;E staining was performed according to standard laboratory protocols. Immunohistochemical stainings were performed on a Ventana BenchMark XT system (Roche Diagnostics). The following primary antibodies were used: SALL4 (ab57577, abcam, 1:50), Ki67 (SP6, Cell Marque, 1:750), SOX2 (ab97959, abcam, 1:1000), MAP2C (M4403, Sigma\u2013Aldrich, 1:3000), CD56 (MSK006, Zytomed, 1:2000), Synaptophysin (M7315, Dako, 1:500). As a chromogen, 3,3\u02b9-diaminobenzine (DAB) was used. </p> </section> <section id=\"s8\"> <h3 class=\"pmc_sec_title\"> Sample Preparation for Mass Spectrometry </h3> <p> Punch biopsies and/or microdissected tissue sections were collected from FFPE embryonal brain tumors. For whole sample analyses, care was taken to compile samples, which sufficiently portray the histomorphology of the entire tumor. For paraffin removal, samples were incubated in 0.5 ml n-heptane at room temperature for 30 min, using a ThermoMixer (ThermoMixer 5436, Eppendorf). Samples were centrifuged at 14 000 g for 5 min and the supernatant was discarded. Samples were reconditioned with 70% ethanol and centrifuged at 14 000 g for 5 min. The supernatant was discarded. The procedure was repeated twice. Deparaffinized tissue samples and fresh frozen cell pellets were dissolved in 150 \u00b5L 1% w/v sodium deoxycholate (SDC) in 0.1 M triethylammonium bicarbonate buffer (TEAB) and incubated for 1 h at 95 \u00b0C for reverse formalin fixation. Samples were sonicated for 5 s at an energy of 25% to destroy interfering DNA. A bicinchoninic acid (BCA) assay was performed (Pierce\u2122 BCA Protein Assay Kit, Thermo Scientific) to determine the protein concentration, following the manufacturer\u2019s instructions. Tryptic digestion was performed for 20 \u03bcg protein, using the single-pot, solid-phase-enhanced sample preparation (SP3) protocol, as described by Hughes et al. <sup> <a aria-describedby=\"CIT0013\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0013\"> 13 </a> </sup> Eluted peptides were dried in a Savant SpeedVac Vacuum Concentrator (Thermo Fisher Scientific) and stored at \u221220 \u00b0C until further use. Directly prior to measurement dried peptides were resolved in 0.1% FA to a final concentration of 1 \u03bcg/\u03bcL. In total 1 \u03bcg was subjected to mass spectrometry analysis. </p> </section> <section id=\"s9\"> <h3 class=\"pmc_sec_title\"> Mass Spectrometry Analyses </h3> <p> Liquid chromatography\u2013tandem mass spectrometer (LC\u2013MS/MS) measurements were performed on a quadrupole-ion-trap-orbitrap mass spectrometer (MS, QExactive, Thermo Fisher Scientific) coupled to a nano-UPLC (Dionex Ultimate 3000 UPLC system, Thermo Fisher Scientific). Tryptic peptides were injected into the LC system via an autosampler, purified, and desalted by using a reversed-phase trapping column (Acclaim PepMap 100 C18 trap; 100 \u03bcm \u00d7 2 cm, 100 A pore size, 5 \u03bcm particle size; Thermo Fisher Scientific), and thereafter separated with a reversed-phase column (Acclaim PepMap 100 C18; 75 \u03bcm \u00d7 25 cm, 100 A pore size, 2 \u03bcm particle size, Thermo Fisher Scientific). Trapping was performed for 5 min at a flow rate of 5 \u00b5L/min with 98% solvent A (0.1% FA) and 2% solvent B (0.1% FA in ACN). Separation and elution of peptides were achieved by a linear gradient from 2% to 30% solvent B in 65 min at a flow rate of 0.3 \u00b5L/min. Eluting peptides were ionized by using a nano-electrospray ionization source (nano-ESI) with a spray voltage of 1800 V, transferred into the MS, and analyzed in data-dependent acquisition (DDA) mode. For each MS1 scan, ions were accumulated for a maximum of 240 ms or until a charge density of 1 \u00d7 1^6 ions (AGC target) was reached. Fourier-transformation-based mass analysis of the data from the orbitrap mass analyzer was performed by covering a mass range of 400\u20141200 <em> m </em> / <em> z </em> with a resolution of 70 000 at <em> m </em> / <em> z </em> = 200. Peptides with charge states between 2+ and 5 + above an intensity threshold of 5000 were isolated within a 2.0 <em> m </em> / <em> z </em> isolation window in top-speed mode for 3 s from each precursor scan and fragmented with a normalized collision energy of 25 %, using higher energy collisional dissociation (HCD). MS2 scanning was performed, using an orbitrap mass analyzer, with a starting mass of 100 <em> m </em> / <em> z </em> at an orbitrap resolution of 17 500 at <em> m </em> / <em> z </em> = 200 and accumulated for 50 ms or to an AGC target of 1 \u00d7 10^5. Already fragmented peptides were excluded for 20 s. </p> </section> <section id=\"s10\"> <h3 class=\"pmc_sec_title\"> Acquisition and Preprocessing of Proteome Data </h3> <p> LC\u2013MS/MS raw spectra were searched against a reviewed human Swissprot database, obtained in February 2022, containing 20 300 entries, using the SEQUEST algorithm integrated into the Proteome Discoverer software (v 3.0, Thermo Fisher Scientific). A maximum number of 2 missing tryptic cleavages was set. Peptides between 6 and 144 amino acids were considered. Carbamidomethylation was set as a fixed modification for cysteine residues and the oxidation of methionine, and pyro-glutamate formation at glutamine residues at the peptide N-terminus, as well as acetylation of the protein N-terminus was allowed as variable modifications. A strict cutoff (false discovery rate (FDR) &lt; 0.01) was set for peptide and protein identification. Protein quantification was carried out, using the Minora Algorithm, implemented in Proteome Discoverer. For quantification, only unique peptides were used. Retrieved protein abundancies were normalized at the protein level, using all proteins quantified. Scaling was disabled. Protein abundances were log2 transformed and normalized using sample-wise median centering. </p> </section> <section id=\"s11\"> <h3 class=\"pmc_sec_title\"> Acquisition of Transcriptome Data </h3> <p> Gene expression data of embryonal brain tumor samples (CEL files) were acquired from the publicly available data sets <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE10327\" rel=\"noopener noreferrer\" target=\"_blank\"> GSE10327 </a> , <sup> <a aria-describedby=\"CIT0014\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0014\"> 14 </a> </sup> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE122077\" rel=\"noopener noreferrer\" target=\"_blank\"> GSE122077 </a> , <sup> <a aria-describedby=\"CIT0006\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0006\"> 6 </a> </sup> <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE70678\" rel=\"noopener noreferrer\" target=\"_blank\"> GSE70678 </a> , <sup> <a aria-describedby=\"CIT0015\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0015\"> 15 </a> </sup> and <a class=\"usa-link\" href=\"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73038\" rel=\"noopener noreferrer\" target=\"_blank\"> GSE73038 </a> . <sup> <a aria-describedby=\"CIT0016\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0016\"> 16 </a> </sup> Sample annotations were obtained from the respective GEO deposits and the corresponding publications. Sample annotations were checked for redundancy. Potential duplicate samples were excluded from the analyses. Sample files were simultaneously processed using Affymetrix TAC4.0 software with default parameters (RNA normalization). Transcripts were collapsed using GSEA software v4.0.3 of the Broad Institute. <sup> <a aria-describedby=\"CIT0017\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0017\"> 17 </a> </sup> </p> </section> <section id=\"s12\"> <h3 class=\"pmc_sec_title\"> Acquisition and Preprocessing of Methylome Data </h3> <p> DNA was isolated using the ReliaPrep\u2122 FFPE gDNA Miniprep System (Promega) according to the manufacturer\u2019s instructions. Approximately 100\u2013500 ng DNA was used for bisulfite conversion by the EZ DNA Methylation Kit (Zymo Research). Afterward, the DNA Clean &amp; Concentrator-5 (Zymo Research) and the Infinium HD FFPE DNA Restore Kit (Illumina) were used to clean and restore the converted DNA. The Illumina Infinium Methylation EPIC BeadChip Kit was used to quantify the methylation status of CpG sites on an Illumina iScan system. Raw methylation array data (idat files) were processed using the minfi package <sup> <a aria-describedby=\"CIT0018\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0018\"> 18 </a> </sup> in R software. <sup> <a aria-describedby=\"CIT0019\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0019\"> 19 </a> </sup> Stratified quantile normalization preprocessing was performed. Probes on sex chromosomes, probes with a detection <em> P </em> -value of or above 0.01, probes with SNPs at the CpG site, and cross-reactive probes were excluded from the analysis. </p> </section> <section id=\"s13\"> <h3 class=\"pmc_sec_title\"> Gene Set Enrichment Analysis (GSEA) </h3> <p> For GSEA of proteome and transcriptome data, proteins and RNAs were ranked according to the product of fold-change and negative log10-transformed <em> P </em> -values comparing ETMR with AT/RT and MB. To obtain histomorphology-independent ranks, the ranking was performed separately for EBL/MEPL and ETANTR cases and the ranks were subsequently combined prior to performing GSEA. Gene set size ranges were set from 10 to 250 for proteins and from 10 to 600 for RNA. All <em> P </em> -values derived from GSEA were BH-adjusted and considered significant with a <em> P </em> -value \u2264 .05. </p> </section> <section id=\"s14\"> <h3 class=\"pmc_sec_title\"> GO Over-Representation Analysis (ORA) </h3> <p> For ORA of proteome data, significant differential protein abundance was determined by Welch\u2019s <em> t </em> -test. <em> P </em> -values \u2264 .05 were considered significant. ORA was performed by testing for GO enrichment of significant proteins within the universe of all proteins represented in the data. Gene set size ranges were set to 10\u2013250 for proteins. GO terms with <em> P </em> -values lower than 0.05 and protein counts higher than 4 were considered over-represented. GO terms with a Resnik\u2019s and Lin\u2019s similarity measure over 0.4 were considered semantically similar. For simplification of category-gene-net (CNET) plots, terms with semantic redundancy to terms with higher significance were removed. For simplification of Venn diagrams, non-overlapping terms with semantic redundancy to overlapping terms were removed. </p> <p> For ORA of methylome data, promotor-associated CpG methylation, and protein levels were investigated for sample-wise Spearman correlation across embryonal brain tumors. Promotor-association was defined as TSS200, TSS1500, or 5\u02b9UTR according to the ChAMP package (version: 2.24.0). <sup> <a aria-describedby=\"CIT0020\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0020\"> 20 </a> </sup> Proteins were considered to correlate significantly with methylation levels when at least one of the gene promotor-associated CpG demonstrated a Benjamini, Hochberg, and Yekutieli (BY)-adjusted <em> P </em> -value \u2264 .05. ORA was performed on all significantly correlating proteins within the universe of all significantly differentially abundant proteins in ETMR. Gene set size ranges were set to 5\u2013150. GO terms were considered over-represented when at least 2 and more than 10% of gene set members showed a significant correlation between protein and methylation levels. </p> </section> <section id=\"s15\"> <h3 class=\"pmc_sec_title\"> Proteome Data Set Integration </h3> <p> Processed proteome data of pediatric brain tumors was obtained from publicly available data sets (PDC000180, <sup> <a aria-describedby=\"CIT0021\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0021\"> 21 </a> </sup> accessed via <a class=\"usa-link usa-link--external\" href=\"https://pdc.cancer.gov\" rel=\"noopener noreferrer\" target=\"_blank\"> https://pdc.cancer.gov </a> ). Batch effects between the individual TMT plexes were corrected using ComBat. <sup> <a aria-describedby=\"CIT0022\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0022\"> 22 </a> </sup> For integration with our case series, the medians of all samples were shifted to 0 and the data was scaled to a median absolute deviation of 1 per sample. COCONUT <sup> <a aria-describedby=\"CIT0023\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0023\"> 23 </a> </sup> was deployed to correct batch effects, using medulloblastomas of the same molecular subtypes (2 SHH-MH, 2 Gr4-MB, 1 WNT-MB) as references between the datasets. The reference samples were excluded in further analyses. Batch effects between proteome data of in-house cell line samples and in-house embryonal brain tumor tissue samples were corrected using ComBat. <sup> <a aria-describedby=\"CIT0022\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0022\"> 22 </a> </sup> </p> </section> <section id=\"s16\"> <h3 class=\"pmc_sec_title\"> Cell Culture </h3> <p> BT183 cells were cultured in NeuroCult NS-A Proliferation Kit (Human), supplemented with heparin (2 \u00b5g/ml), epidermal growth factor (EGF; 20 ng/mL), and fibroblast growth factor (FGF; 20 ng/ml) (STEMCELL Technologies). BT16 were grown in Roswell Park Memorial Institute medium (RPMI 1640 (+ <span class=\"font-variant-small-caps\"> l </span> -Glutamine)), including 15% fetal bovine serum (FBS) and 25 mM HEPES buffer (Gibco, Thermo Fisher Scientific). D283 were grown in Eagle\u2019s Minimum Essential Medium (EMEM) (ATCC) including 10% FBS. Media were additionally supplemented with 100 U/ml penicillin/streptomycin (Gibco, Thermo Fisher Scientific). All cell line identities were confirmed via cell line authentication services (Eurofins Genomics) and/or global DNA methylation profiling. </p> </section> <section id=\"s17\"> <h3 class=\"pmc_sec_title\"> Cell Viability Assays </h3> <p> Cells were seeded onto white 96-well plates and incubated for 16 h. Marizomib (SML1916, Sigma-Aldrich) was added at different concentrations in 6 technical replicates. After 72 h, cell viability was measured using the CellTiter-Glo reagent (Promega) according to the manufacturer\u2019s instructions. Luminescence was measured using an automated plate reader (GloMax Discover microplate reader). Dose\u2013response curves and half-maximal inhibitory concentration (IC <sub> 50 </sub> ) values were calculated with GraphPad Prism software v8.4.3. </p> </section> <section id=\"s18\"> <h3 class=\"pmc_sec_title\"> Data and Image Processing </h3> <p> Computational analyses were performed using the R software. <sup> <a aria-describedby=\"CIT0019\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0019\"> 19 </a> </sup> GSEA and ORA analyses were performed using the clusterProfiler package (version: 4.2.2). <sup> <a aria-describedby=\"CIT0024\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0024\"> 24 </a> </sup> Single sample GSEA (ssGSEA) was performed using the GSVA package (version: 1.42.0). <sup> <a aria-describedby=\"CIT0025\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0025\"> 25 </a> </sup> Non-negative matrix factorization was performed using the NMF package (version: 0.26) <sup> <a aria-describedby=\"CIT0026\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0026\"> 26 </a> </sup> on processed and scaled log2 transformed protein data. Proteins were searched for potential targets with the use of QIAGEN IPA (QIAGEN Inc., <a class=\"usa-link usa-link--external\" href=\"https://digitalinsights.qiagen.com/IPA\" rel=\"noopener noreferrer\" target=\"_blank\"> https://digitalinsights.qiagen.com/IPA </a> ). <sup> <a aria-describedby=\"CIT0027\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0027\"> 27 </a> </sup> Tissue slides were digitalized with a Hamamatsu NanoZoomer 2.0-HT C9600 whole slide scanner and representative tissue images were exported using NDP.view v2.7.43 software. All figures containing images and graphs were processed using Adobe Illustrator 25.2.1. </p> </section> <section id=\"s19\"> <h3 class=\"pmc_sec_title\"> Data Availability </h3> <p> The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE <sup> <a aria-describedby=\"CIT0028\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0028\"> 28 </a> </sup> partner repository with the dataset identifier PXD045268. </p> </section> </section> <section id=\"s20\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"s20-anchor\"> </a> Results </h2> <p> We assembled a case series of 40 embryonal brain tumors (16 ETMR, 9 AT/RT, 15 MB). ETMR diagnoses had been molecularly confirmed through evidence of a C19MC amplification via fluorescence in situ hybridization (FISH) and/or an ETMR-specific epigenetic profile (MNP classifier match with the methylation class \u201cEmbryonal tumor with multilayered rosettes\u201d using v11b4 or v12.5 ( <a class=\"usa-link\" href=\"#sup9\"> Supplementary Table 1 </a> , <a class=\"usa-link\" href=\"#sup1\"> Supplementary Figure 1 </a> ). <sup> <a aria-describedby=\"CIT0029\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0029\"> 29 </a> </sup> Representative FFPE tumor material of all cases was subjected to proteome analyses via liquid chromatography coupled with tandem mass spectrometry (LC\u2013MS/MS). </p> <section id=\"s21\"> <h3 class=\"pmc_sec_title\"> ETMR Proteomics Strongly Relate to Histological Subtypes </h3> <p> First, we aimed to explore the proteome landscape of the ETMR case series. To illustrate similarities and differences between the samples, we employed hierarchical cluster analyses. We found that ETMR separated into 2 distinct and stable proteome subgroups ( <a class=\"usa-link\" href=\"#F1\"> Figure 1A </a> ; <a class=\"usa-link\" href=\"#sup2\"> Supplementary Figure 2A and B </a> ). The first subgroup harbored all tumors, with either EBL or MEPL ( <a class=\"usa-link\" href=\"#F1\"> Figure 1A\u2013C </a> ) morphology, whereas the second subgroup harbored all tumors classified as ETANTR ( <a class=\"usa-link\" href=\"#F1\"> Figure 1A </a> and <a class=\"usa-link\" href=\"#F1\"> D </a> ). Of note, the latter group contained 2 ETMR cases without C19MC amplification, which did not specifically separate from C19MC-altered tumors ( <a class=\"usa-link\" href=\"#F1\"> Figure 1A </a> ; <a class=\"usa-link\" href=\"#sup2\"> Supplementary Figure 2A and B </a> ; <a class=\"usa-link\" href=\"#sup3\"> Supplementary Figure 3A\u2013J </a> ). We next investigated the differential proteomics of these 2 subgroups, focusing on the proteins with significantly differential abundance in ETANTR compared to EBL/MEPL cases ( <a class=\"usa-link\" href=\"#F1\"> Figure 1E </a> ; <a class=\"usa-link\" href=\"#sup10\"> Supplementary Table 2A </a> ). Through gene ontology (GO) over-representation analysis (ORA), we found an enrichment of proteins relating to stemness, developmental processes, and chromosome organization in EBL/MEPL cases ( <a class=\"usa-link\" href=\"#F1\"> Figure 1F </a> ; <a class=\"usa-link\" href=\"#sup3\"> Supplementary Figure 3A </a> ; <a class=\"usa-link\" href=\"#sup10\"> Supplementary Table 2B </a> ). In the ETANTR cases, on the other hand, we found an enrichment of proteins relating to neuronal signatures ( <a class=\"usa-link\" href=\"#F1\"> Figure 1G </a> ; <a class=\"usa-link\" href=\"#sup3\"> Supplementary Figure 3A </a> ; <a class=\"usa-link\" href=\"#sup10\"> Supplementary Table 2C </a> ). </p> <figure class=\"fig xbox font-sm\" id=\"F1\"> <h4 class=\"obj_head\"> Figure 1. </h4> <p class=\"img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center\"> <a class=\"tileshop\" href=\"https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11066909_noad265_fig1.jpg\" target=\"_blank\"> <img alt=\"Figure 1.\" class=\"graphic zoom-in\" height=\"933\" loading=\"lazy\" src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b831/11066909/220d8a257528/noad265_fig1.jpg\" width=\"722\"/> </a> </p> <div class=\"p text-right font-secondary\"> <a class=\"usa-link\" href=\"figure/F1/\" rel=\"noopener noreferrer\" target=\"_blank\"> Open in a new tab </a> </div> <figcaption> <p> ETMR proteomics are closely associated with histomorphology (A) Consensus clustering of proteome data shows that ETMR samples cluster according to their histological variants. Cases are separated into a proteome subgroup of ependymoblastomas (EBL) and medulloepitheliomas (MEPL) and another proteome subgroup of embryonal tumors with abundant neuropil and true rosettes (ETANTR). Tissue samples were prepared to be representative of the morphology of the entire tumor. Clustering was based on the 1000 most variant proteins, Euclidean distance, and ward.D2 linkage. <em> K </em> = 2 is shown. (B) <strong> \u2014 </strong> (D) Representative images of ETMR histological variants. EBL shows multilayered rosettes surrounding small lumina (B). MEPL exhibits epithelioid features with columnar or tubular architecture (C). ETANTR are characterized by vast areas of eosinophilic fibrillary matrix and occasional rosettes (D). Scale bar is 100 \u00b5m in B\u2014D. <strong> (E) </strong> Volcano plot shows differentially abundant proteins comparing ETANTR to EBL/MEPL tumors. Fold-changes of mean abundancies are shown. Welch\u2019s <em> t </em> -test. (F) Gene ontology (GO) category-gene-net (CNET) plot of the top 5 significant results derived from GO overrepresentation analysis (ORA) in all proteins with significantly higher abundance in EBL/MEPL compared to ETANTR. GO subontology: biological process (BP). (G) GO CNET plot of the top 5 significant results of ORA in all proteins with significantly higher abundance in ETANTR compared to EBL/MEPL. GO subontology: BP. (H\u2014AE) Representative protein markers and corresponding immunohistochemical stains demonstrate the influence of neuropil-rich areas on ETMR proteomics. Stemness- and proliferation-associated markers like SOX2 (H-K), MKI67 (KI67, P-S), and SALL4 (X-AA) are strongly expressed in EBL/MEPL and the rosettes of ETANTR. Neuronal markers like NCAM1 (CD56, L-O), MAP2 (MAP2C, T-W), and Synaptophysin (SYP, AB-AE) are predominantly expressed in the neuropil of ETANTR. * <em> P </em> \u2264 .05, ** <em> P </em> &lt; .01, *** <em> P </em> &lt; 0.001, Welch\u2019s <em> t </em> -test. Scale bar is 100 \u00b5m in all histological images in H\u2014AE. </p> </figcaption> </figure> <p> We, therefore, hypothesized that the ETMR neuropil portrays the histomorphological correlate of neuronal differentiation, and suspected that the ETMR neuropil directs the proteome subgroup affiliation. Immunohistochemical stainings ( <a class=\"usa-link\" href=\"#F1\"> Figure 1H </a> \u2013AE) confirmed that tumor cells in areas with undifferentiated, rosette-like, or epithelioid morphology of EBL/MEPL cases, as well as rosette structures of ETANTR cases were immunopositive for stemness- and proliferation-associated markers like SOX2, KI67, and SALL4. In contrast, the neuropil-rich areas of ETANTR, were immunonegative for these markers, but instead stained intensely for neuronal markers like CD56, MAP2C, and synaptophysin. </p> </section> <section id=\"s22\"> <h3 class=\"pmc_sec_title\"> Tumor Morphology Overpowers Tumor Identity in ETMR Proteomics </h3> <p> Next, we aimed to demonstrate the magnitude of morphology and proteome interconnection in ETMR. Three of the 16 ETMR (cases #5, #11 and #12) were exceptionally heterogeneous and showed vast, well-demarcated areas of either neuropil-rich (ETANTR-like) or primitive (EBL/MEPL-like) architecture. Both areas were microdissected and separately subjected to proteome measurements in all 3 cases (Figure 2A). The consensus clustering showed that the 6 generated samples clustered according to tissue morphology and not according to the tumor\u2019s superordinate histological subtype or the tumor\u2019s identity ( <a class=\"usa-link\" href=\"#F2\"> Figure 2B </a> ; <a class=\"usa-link\" href=\"#sup2\"> Supplementary Figure 2C and D </a> ). We continued to investigate proteins with intratumoral differential abundance in neuropil-rich compared to primitive areas. Stemness- and proliferation-associated markers like SOX2, PCNA, and HMGA2, were found in higher abundance in the primitive areas ( <a class=\"usa-link\" href=\"#F2\"> Figure 2C </a> , <a class=\"usa-link\" href=\"#F2\"> E </a> , <a class=\"usa-link\" href=\"#F2\"> G </a> ; <a class=\"usa-link\" href=\"#sup4\"> Supplementary Figure 4B </a> ), whereas neuronal markers such as CD56, MAP2C, and synaptophysin, were found in higher abundance in neuropil-rich areas ( <a class=\"usa-link\" href=\"#F2\"> Figure 2D </a> , <a class=\"usa-link\" href=\"#F2\"> F </a> , <a class=\"usa-link\" href=\"#F2\"> H </a> ; <a class=\"usa-link\" href=\"#sup4\"> Supplementary Figure 4D </a> ). Finally, we found that GO enrichment relating to intratumoral differential proteome profiles was highly analogous to the intertumoral differential proteomics ( <a class=\"usa-link\" href=\"#F2\"> Figure 2I </a> ; <a class=\"usa-link\" href=\"#sup11\"> Supplementary Table 3A\u2013D </a> ). We concluded that the heterogeneity of ETMR proteomics is primarily reflective of histomorphological features, regardless of inter- or intra-tumor comparisons. </p> <figure class=\"fig xbox font-sm\" id=\"F2\"> <h4 class=\"obj_head\"> Figure 2. </h4> <p class=\"img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center\"> <a class=\"tileshop\" href=\"https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11066909_noad265_fig2.jpg\" target=\"_blank\"> <img alt=\"Figure 2.\" class=\"graphic zoom-in\" height=\"611\" loading=\"lazy\" src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b831/11066909/6cee35b70b90/noad265_fig2.jpg\" width=\"800\"/> </a> </p> <div class=\"p text-right font-secondary\"> <a class=\"usa-link\" href=\"figure/F2/\" rel=\"noopener noreferrer\" target=\"_blank\"> Open in a new tab </a> </div> <figcaption> <p> ETMR proteome profiles associate with histomorphological heterogeneity between and within tumors (A) 3 ETMR with demarcated areas of primitive (EBL/MEPL-like) and neuropil-rich (ETANTR-like) morphology were subjected to microdissection with subsequent separate proteome analyses of both tumor areas. Scale bar is 100 \u00b5m in insets. (B) Consensus clustering of 3 microdissected tumors shows that microdissected samples cluster according to histomorphology of the tumor area, overpowering the superordinated histological tumor subtype and the patient/tumor identity. Clustering was based on the 1000 most variant proteins, Euclidean distance, and ward.D2 linkage. <em> K </em> = 2 is shown. (C\u2014H) Representative proteins demonstrate the presence of proliferation and stemness markers (SOX2 (C), PCNA (E), and HMGA2 (G)) in the primitive areas and the presence of neuronal markers (NCAM1 (D), MAP2 (F), and SYP (H)) in the neuropil-rich areas. * <em> P </em> \u2264 .05, ** <em> P </em> &lt; 0.01, paired <em> t </em> -test. <strong> (i) </strong> Comparison of functional enrichment in intra- vs. intertumoral differential proteomics. Left volcano plot shows the intra-tumorally differentially abundant proteins comparing neuropil-rich (ETANTR-like) with primitive (EBL/MEPL-like) tumor areas (paired <em> t </em> -test). Right volcano plot shows the inter-tumorally differentially abundant proteins comparing ETANTR with EBL and MEPL (Welch\u2019s <em> t </em> -test). Venn diagrams show the overlap of terms derived from separate ORA of significantly differentially abundant proteins. GO subontology: BP. </p> </figcaption> </figure> </section> <section id=\"s23\"> <h3 class=\"pmc_sec_title\"> Comparative Proteomics in Embryonal Brain Tumors Reveal Unique Proteome Features of ETMR </h3> <p> We continued to compare ETMR proteome signatures to those of other malignant pediatric embryonal brain tumors (9 AT/RT and 15 MB; <a class=\"usa-link\" href=\"#sup9\"> Supplementary Table 1 </a> ). Consensus clustering of embryonal brain tumors showed that ETMR proteome signatures are distinct from AT/RT and MB (Figure 3A). Notably, histomorphological subtypes of AT/RT <sup> <a aria-describedby=\"CIT0030\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0030\"> 30 </a> </sup> and MB <sup> <a aria-describedby=\"CIT0031\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0031\"> 31 </a> </sup> did not associate with tumor entity subclusters nearly as evidently as in ETMR ( <a class=\"usa-link\" href=\"#F3\"> Figure 3A\u2013H </a> ; <a class=\"usa-link\" href=\"#sup2\"> Supplementary Figure 2E and F </a> ). We next aimed to further investigate unique proteome features of ETMR in search of potential therapeutic vulnerabilities. </p> <figure class=\"fig xbox font-sm\" id=\"F3\"> <h4 class=\"obj_head\"> Figure 3. </h4> <p class=\"img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center\"> <a class=\"tileshop\" href=\"https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11066909_noad265_fig3.jpg\" target=\"_blank\"> <img alt=\"Figure 3.\" class=\"graphic zoom-in\" height=\"783\" loading=\"lazy\" src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b831/11066909/6aa2e62a5562/noad265_fig3.jpg\" width=\"723\"/> </a> </p> <div class=\"p text-right font-secondary\"> <a class=\"usa-link\" href=\"figure/F3/\" rel=\"noopener noreferrer\" target=\"_blank\"> Open in a new tab </a> </div> <figcaption> <p> Embryonal brain tumor proteomics showcase distinct features of ETMR (A) Consensus clustering of proteome data shows that ETMR samples cluster separately from other embryonal brain tumors (AT/RT and MB). Of note, histomorphology dictates proteome clustering in ETMR more strongly than in AT/RT and MB. Clustering was based on the 1000 most variant proteins, Euclidean distance, and ward.D2 linkage. <em> K </em> = 5 is shown. (B)\u2014(H) Representative images of histological variants of AT/RT and MB. AT/RT tumor morphology was rhabdoid with abundant eosinophilic cytoplasm and eccentrically located nuclei (B), epithelioid with cohesive growth and formation of surfaces (C), mesenchymal with spindled cells and desmoplasia (D) or undifferentiated with basophilic small-blue-round (SBR) appearance of cells (E). MB tumor morphology was classic with densely packed, poorly differentiated cells (F), desmoplastic/nodular (D/N) with islands of tumor cells separated by connective tissue fibers (G) or extensively nodular (MBEN, H). Scale bar is 100 \u00b5m in B\u2014H. (I) Volcano plot shows differentially abundant proteins of ETMR compared to AT/RT and MB. Coloring indicates ETMR histomorphology-independent significant differential abundance. Significance was considered histomorphology-independent, when proteins showed a |fc| &gt; 1 and <em> P </em> -value \u2264 .05 in ETANTR as well as EBL/MEPL compared to AT/RT and MB. Welch\u2019s <em> t </em> -test. (J) Lollipop plot shows representative GO terms associated with differentially abundant proteins in ETMR compared to AT/RT and MB. The shown terms were significant and morphology-independent in both ORA and GSEA. ORA statistics are shown. GO subontology: BP, molecular function (MF) and cellular component (CC). (K) CNET plot shows the linkage of significant GO terms, proteins, and protein fold changes comparing ETMR with AT/RT and MB. Of note \u201cproteasome regulatory particle\u201d proteins are consistently higher abundant in ETMR compared to AT/RT and MB. </p> </figcaption> </figure> <p> Intratumoral heterogeneity poses a persistent challenge in cancer therapy, as it can foster tumor evolution under the selective pressure of medical treatments. <sup> <a aria-describedby=\"CIT0032\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0032\"> 32 </a> </sup> Given the close association of histomorphology and proteome profiles we found between, but also within ETMR, we inferred that proteome features attributable to both proteome subgroups constitute the most promising prospect for novel therapeutic approaches. To identify intratumorally pervasive proteome features of ETMR, we focused our analyses on proteins with histomorphology-independent significantly differential abundance in ETMR compared to AT/RT and MB ( <a class=\"usa-link\" href=\"#F3\"> Figure 3I </a> ; <a class=\"usa-link\" href=\"#sup12\"> Supplementary Table 4A\u2013C </a> ). Of note, the RNA binding protein LIN28A, which is considered a characteristic immunohistochemical marker in ETMR, was found among the significant candidate proteins (fold change = 2.84 and *** <em> P </em> &lt; .001; <a class=\"usa-link\" href=\"#sup12\"> Supplementary Table 4A </a> ). Significant proteins were subjected to ORA ( <a class=\"usa-link\" href=\"#sup12\"> Supplementary Table 4B </a> ) and, additionally, gene set enrichment analyses (GSEA) were performed ( <a class=\"usa-link\" href=\"#sup12\"> Supplementary Table 4C </a> ). We identified the terms \u201cproteasome regulatory particle\u201d, \u201cregulation of interleukin-8 production\u201d, \u201cgene silencing by miRNA\u201d, \u201ctranslation regulator activity\u201d, \u201cDNA replication\u201d, and \u201cmicrotubule-based process\u201d to be representative of the significantly enriched GO terms in both analyses ( <a class=\"usa-link\" href=\"#F3\"> Figure 3J </a> , <a class=\"usa-link\" href=\"#sup12\"> Supplementary Table 4B and C </a> ). Notably, \u201cproteasome regulatory particle\u201d was the most significant gene set hit (*** <em> P </em> &lt; .001) and exclusively comprised gene set members with higher protein abundance in ETMR independent of histomorphology ( <a class=\"usa-link\" href=\"#F3\"> Figure 3K </a> ). The prominence of these gene sets as histomorphology-independent features of ETMR was confirmed by separate ORA of EBL/MEPL and ETANTR ( <a class=\"usa-link\" href=\"#sup5\"> Supplementary Figure 5A and B </a> ). The QIAGEN Ingenuity Pathway Analysis (IPA) platform was used to search for potential therapeutic targets in the ETMR proteome. <sup> <a aria-describedby=\"CIT0027\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0027\"> 27 </a> </sup> A search based on proteins, which were highly abundant in ETMR independent of histomorphology revealed proteasome inhibition as a potential target ( <a class=\"usa-link\" href=\"#sup13\"> Supplementary Table 5A </a> ). Moreover, analysis of EBL/MEPL-specific proteins pointed out TOP2A inhibitors such as anthracyclins ( <a class=\"usa-link\" href=\"#sup13\"> Supplementary Table 5B </a> ). Abundance of the synaptic protein SV2A in ETANTR associated with antiepileptic anticancer drugs like levetiracetam ( <a class=\"usa-link\" href=\"#sup13\"> Supplementary Table 5C </a> ). </p> </section> <section id=\"s24\"> <h3 class=\"pmc_sec_title\"> Integrated Proteomics of Embryonal Brain Tumors Decipher Highly and Poorly Epigenetically Conserved Pathways in ETMR </h3> <p> To further explore ETMR tumor biology, we acquired transcriptome data of ETMR, AT/RT, and MB from publicly available datasets ( <a class=\"usa-link\" href=\"#sup14\"> Supplementary Table 6 </a> ). <sup> <a aria-describedby=\"CIT0006\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0006\"> 6 </a> , <a aria-describedby=\"CIT0014\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0014\"> 14\u201316 </a> </sup> Consensus clustering of the compiled data confirmed robust clustering of tumor entities based on transcriptome profiles ( <a class=\"usa-link\" href=\"#sup6\"> Supplementary Figure 6A </a> ), as previously described. <sup> <a aria-describedby=\"CIT0016\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0016\"> 16 </a> </sup> Tissue from a subset of embryonal brain tumors of our case series was also available for global DNA methylation analysis ( <em> n </em> = 28). As expected, and previously described, <sup> <a aria-describedby=\"CIT0029\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0029\"> 29 </a> </sup> consensus clustering based on methylome data showcased robust clustering of samples according to tumor entities ( <a class=\"usa-link\" href=\"#sup6\"> Supplementary Figure 6B </a> ). We proceeded to explore GO term enrichment in ETMR via GSEA on the 3 different <em> omic </em> datasets, reflecting steps of the central dogma of gene expression (ie protein, RNA, and DNA promoter methylation). Subsequently, we searched for overlap of GO terms separately detected in all 3 analyses ( <a class=\"usa-link\" href=\"#F4\"> Figure 4A </a> , <a class=\"usa-link\" href=\"#sup15\"> Supplementary Table 7 </a> ). </p> <figure class=\"fig xbox font-sm\" id=\"F4\"> <h4 class=\"obj_head\"> Figure 4. </h4> <p class=\"img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center\"> <a class=\"tileshop\" href=\"https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11066909_noad265_fig4.jpg\" target=\"_blank\"> <img alt=\"Figure 4.\" class=\"graphic zoom-in\" height=\"626\" loading=\"lazy\" src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b831/11066909/79c4082388e9/noad265_fig4.jpg\" width=\"800\"/> </a> </p> <div class=\"p text-right font-secondary\"> <a class=\"usa-link\" href=\"figure/F4/\" rel=\"noopener noreferrer\" target=\"_blank\"> Open in a new tab </a> </div> <figcaption> <p> Integrated proteomics add new insights to ETMR molecular biology and reflect transcriptome-based features (A) Venn diagram demonstrates the quantitative overlap of GO term enrichment associated with the proteome, transcriptome, and methylome of ETMR. GO enrichment in the proteome and transcriptome was determined via GSEA comparing ETMR to AT/RT and MB. GO enrichment in the methylome was determined via GO over-representation analysis of proteins showing a significant correlation with their promotor methylation levels. (B\u2014D) Bar graphs show selected GO terms, which were either associated with molecular signatures reflected in the ETMR proteome exclusively (B), with signatures reflected in the ETMR proteome and transcriptome (C), or with signatures reflected in the ETMR proteome, transcriptome as well as the methylome (D). Protein level GSEA statistics in ETMR are shown. NES: normalized enrichment score. BH-adjusted <em> P </em> -values: * <em> P </em> \u2264 .05, ** <em> P </em> &lt; .01, *** <em> P </em> &lt; 0.001. GO subontology: BP, MF and CC. (E\u2014V) Enrichment analyses results are shown for 3 selected GO terms and their association with the ETMR proteome (E\u2014J), transcriptome (K\u2014P), and methylome (Q\u2014V): \u201cATP hydrolysis activity\u201d (E, K, Q), \u201cregulation of microtubule organization\u201d (G, M, S) and \u201cregulation of translation\u201d (I, O, U). Protein and RNA levels as well as correlation plots of proteins and promotor methylation levels are representatively shown for the proteins KIF21A (F, L, R), HSPB1A (H, N, T), and IGF2BP2 (J, P, V). All <em> P </em> -values derived from GSEA were BH-adjusted. * <em> P </em> \u2264 .05, ** <em> P </em> &lt; .01, *** <em> P </em> &lt; .001. </p> </figcaption> </figure> <p> We identified 107 GO terms of gene sets enriched in ETMR exclusively in the proteome. Among the significantly positively enriched terms was again the \u201cproteasome regulatory particle.\u201d Among the significantly negatively enriched terms were, among others, the \u201cmitochondrial respiratory chain complex I\u201d, \u201coxygen binding\u201d, and \u201cNADH dehydrogenase activity\u201d ( <a class=\"usa-link\" href=\"#F4\"> Figure 4B </a> ; <a class=\"usa-link\" href=\"#sup15\"> Supplementary Table 7A </a> ). </p> <p> We identified 90 GO terms of gene sets enriched in both the proteome and transcriptome of ETMR. Among the significantly positively enriched terms we identified, as expected from previous work, <sup> <a aria-describedby=\"CIT0002\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0002\"> 2 </a> , <a aria-describedby=\"CIT0006\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0006\"> 6 </a> , <a aria-describedby=\"CIT0033\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0033\"> 33 </a> </sup> \u201chelicase activity\u201d, \u201cRNA splicing\u201d, \u201cchromatin remodeling\u201d, \u201chistone binding\u201d and \u201cDNA repair\u201d ( <a class=\"usa-link\" href=\"#F4\"> Figure 4C </a> ; <a class=\"usa-link\" href=\"#sup15\"> Supplementary Table 7B </a> ). </p> <p> GSEA results generated by separately investigating EBL/MEPL and ETANTR confirmed that the aforementioned GO terms were attributable to ETMR independent of histomorphology ( <a class=\"usa-link\" href=\"#sup5\"> Supplementary Figure 5C </a> ). </p> <p> As epigenetically conserved features, we identified 12 GO terms with overlapping representation in the proteome, transcriptome as well as the methylome of ETMR. We determined \u201cmRNA binding\u201d, \u201cATP hydrolysis activity\u201d, \u201cregulation of microtubule cytoskeleton organization\u201d, \u201cregulation of translation\u201d, and \u201cGTPase binding\u201d to best portray these terms ( <a class=\"usa-link\" href=\"#F4\"> Figure 4D </a> ; <a class=\"usa-link\" href=\"#sup15\"> Supplementary Table 7C </a> ). Among the protein members of these gene sets, HNRNPAB, IFG2BP2, HSPA1B, KIF21A, ANXA2, and NCKAP1 showed significant correlation with their respective genes\u2019 promotor methylation levels ( <a class=\"usa-link\" href=\"#sup15\"> Supplementary Table 7E </a> ). Of note, KIF21A and IGF2BP2 were also among the proteins we identified to simultaneously display significantly higher protein abundance, higher RNA levels, and lower promotor methylation levels in ETMR ( <a class=\"usa-link\" href=\"#F4\"> Figure 4E\u2013V </a> , <a class=\"usa-link\" href=\"#sup15\"> Supplementary Figure 7 </a> ). Our results suggest these genes to be highly epigenetically conserved in ETMR. </p> </section> <section id=\"s25\"> <h3 class=\"pmc_sec_title\"> Proteasome Regulatory Protein Abundancy Is a Unique Molecular Characteristic of ETMR </h3> <p> We continued to focus our investigations on the abundance of proteasome regulatory particle proteins in ETMR. This finding was of particular interest since it represented a highly significant novel molecular feature of ETMR that did not associate with intratumoral histomorphology-based heterogeneity and was not reflected on preceding levels of gene expression regulation, i.e. RNA or DNA methylation ( <a class=\"usa-link\" href=\"#F5\"> Figure 5A\u2013Q </a> ). We integrated our proteome data set of embryonal brain tumors with publicly available protein data of other pediatric brain tumors, comprising the tumor entities ependymoma, craniopharyngioma, ganglioglioma, high- and low-grade glioma as well as further AT/RT and MB cases. <sup> <a aria-describedby=\"CIT0021\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0021\"> 21 </a> </sup> Comparisons across pediatric brain tumor entities demonstrated that proteasome regulatory protein abundance was the highest in ETMR (*** <em> P </em> &lt; .001), underlining the distinctiveness of this molecular feature ( <a class=\"usa-link\" href=\"#F5\"> Figure 5R </a> and <a class=\"usa-link\" href=\"#F5\"> S </a> ). </p> <figure class=\"fig xbox font-sm\" id=\"F5\"> <h4 class=\"obj_head\"> Figure 5. </h4> <p class=\"img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center\"> <a class=\"tileshop\" href=\"https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11066909_noad265_fig5.jpg\" target=\"_blank\"> <img alt=\"Figure 5.\" class=\"graphic zoom-in\" height=\"830\" loading=\"lazy\" src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b831/11066909/2695e42e289e/noad265_fig5.jpg\" width=\"720\"/> </a> </p> <div class=\"p text-right font-secondary\"> <a class=\"usa-link\" href=\"figure/F5/\" rel=\"noopener noreferrer\" target=\"_blank\"> Open in a new tab </a> </div> <figcaption> <p> Proteasome regulatory particle proteins are highly abundant in ETMR (A) GSEA curve of the \u201cproteasome regulatory particle\u201d gene set based on protein abundancies comparing ETMR to AT/RT and MB. <em> P </em> -value was BH-adjusted. (B) Proteome heatmap shows a pervasive abundance of proteasome regulatory particles in ETMR compared to AT/RT and MB. (C\u2014E) Plots show protein levels of the 3 top ranked proteasome regulatory particle gene set members PSMD6 (C), PSMC5 (D), and PSMD3 (E). *** <em> P </em> &lt; .001. Welch\u2019s <em> t </em> -test. (F\u2014H) Microdissection analyses confirm that protein abundance of PSMD6 (F), PSMC5 (G), and PSMD3 (H) is not associated with histomorphology of ETMR. (I) GSEA curve of the \u201cproteasome regulatory particle\u201d gene set based on RNA levels comparing ETMR to AT/RT and MB shows no significant enrichment for ETMR. <em> P </em> -value was BH-adjusted. (J) Transcriptome heatmap of \u201cproteasome regulatory particle\u201d RNA levels appears noisy across embryonal brain tumors. (K\u2014M) Plots show RNA levels of the 3 top ranked proteasome regulatory particle gene set members PSMD6 (K), PSMC5 (L), and PSMD3 (M). No significant fold changes can be seen. <em> P </em> -values were BH-adjusted. ns: not significant. Welch\u2019s <em> t </em> -test. (N) Lollipop plot shows the correlation of protein and promotor methylation levels of \u201cproteasome regulatory particle\u201d gene set members. No members show a significant correlation with any CpG sites associated with their respective promotor regions. Spearman correlation. <em> P </em> -values were BY-adjusted. ns = not significant. (O\u2014Q) Plots show protein levels and the methylation levels of the representative promotor CpG sites across embryonal brain tumors. No significant correlation is seen in the 3 top ranked proteasome regulatory particle gene set members PSMD6 (O), PSMC5 (P), and PSMD3 (Q). (R, S) Integrated proteome data of our study and publicly available proteome data of further pediatric brain tumors (Petralia et al.) demonstrates that the abundancy of proteasome regulatory particles is a prominent molecular feature of ETMR. Median protein abundance of all \u201cproteasome regulatory particle\u201d gene set members are shown across entities (R) and comparing overlapping entities (AT/RT and MB) represented in both datasets (S). The latter plot confirms that differential protein levels do not relate to batch effects. *** <em> P </em> &lt; .001. Welch\u2019s test. </p> </figcaption> </figure> </section> <section id=\"s26\"> <h3 class=\"pmc_sec_title\"> Proteasome Inhibition Poses a Promising Therapeutic Approach in ETMR </h3> <p> We hypothesized that the abundance of proteasome regulatory proteins reflects a strong dependency of ETMR on the proteasome to safeguard proteostasis. To prove this concept in vitro, we proceeded to investigate the embryonal brain tumor cell line BT183, which was derived from a C19MC-amplified ETMR with large areas of neuropil in the posterior fossa of a 2-year-old boy. <sup> <a aria-describedby=\"CIT0034\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0034\"> 34 </a> </sup> Proteome data were generated from BT183, as well as the AT/RT cell line BT16, and the MB cell line D283. The proteome profiles of these cell lines adequately matched with their respective tumor entity (Figure 6A). Of note, the BT183 proteome profile best matched with ETANTR profiles ( <a class=\"usa-link\" href=\"#sup8\"> Supplementary Figure 8A\u2013E </a> ) and, in analogy to the results derived from ETMR tissue samples, showed ETMR-characteristic significant abundance of proteins associated with microtubule-based processes and DNA repair ( <a class=\"usa-link\" href=\"#F3\"> Figure 3K </a> ; <a class=\"usa-link\" href=\"#F4\"> Figure 4C </a> , <a class=\"usa-link\" href=\"#F4\"> D </a> ; <a class=\"usa-link\" href=\"#F6\"> Figure 6B </a> and <a class=\"usa-link\" href=\"#F6\"> C </a> ). Moreover, as in the tissue samples, proteasome regulatory particles were highly abundant and NADH dehydrogenase activity proteins were significantly less abundant in BT183 compared to BT16 and D283 (Figure 4B; <a class=\"usa-link\" href=\"#F5\"> Figure 5A\u2013E </a> ; <a class=\"usa-link\" href=\"#F6\"> Figure 6E </a> and <a class=\"usa-link\" href=\"#F6\"> F </a> ). We therefore concluded that these cell lines were suitable to test the potential therapeutic vulnerability of ETMR against proteasome inhibition and proceeded to perform in vitro experiments. All cell lines were treated with the CNS-penetrant proteasome inhibitor Marizomib and assayed for cell viability. We found that BT183 was exceptionally vulnerable toward treatment with Marizomib (IC50 = 56 nM) compared to BT16 and D283 (IC50s \u2248 443 nM, and 333 nM, respectively; <a class=\"usa-link\" href=\"#F6\"> Figure 6D </a> ). In summary, we demonstrated that proteasome regulatory particle abundance is a distinctive, histology-independent feature of ETMR and that proteasome inhibition represents a promising therapeutic vulnerability in ETMR. </p> <figure class=\"fig xbox font-sm\" id=\"F6\"> <h4 class=\"obj_head\"> Figure 6. </h4> <p class=\"img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center\"> <a class=\"tileshop\" href=\"https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11066909_noad265_fig6.jpg\" target=\"_blank\"> <img alt=\"Figure 6.\" class=\"graphic zoom-in\" height=\"561\" loading=\"lazy\" src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b831/11066909/e2ce0d1b056f/noad265_fig6.jpg\" width=\"778\"/> </a> </p> <div class=\"p text-right font-secondary\"> <a class=\"usa-link\" href=\"figure/F6/\" rel=\"noopener noreferrer\" target=\"_blank\"> Open in a new tab </a> </div> <figcaption> <p> Proteasome inhibition represents a promising therapeutic vulnerability in ETMR (A) UMAP plot shows that the proteome profiles of the cell lines BT183, BT16, and D283 adequately match with ETMR, AT/RT, and MB tumor tissue, respectively. UMAP dimension reduction was based on the top 1000 most significant proteins of an ANOVA test between ETMR, AT/RT and MB tissue samples. (B\u2014C) Median protein abundance of all \u201cMicrotubule-based process\u201d and \u201cDNA repair\u201d gene set members are shown in BT183, BT16 and D283. Proteins of both gene sets are significantly more abundant in BT183 compared to BT16 and D283. ** <em> P </em> &lt; .01. Welch\u2019s <em> t </em> -test. (D) Cell titer glo viability assay of BT183 (ETMR), BT16 (AT/RT), and D283 (MB) cell lines treated with the CNS penetrant proteasome inhibitor Marizomib at different concentrations. BT183 ETMR cells are highly vulnerable towards Marizomib treatment, also in comparison with other embryonal tumor cell lines. Four parameter logistic (4PL) curve regression model. (E\u2014F) Median protein abundance of all \u201cProteasome regulatory particles\u201d and \u201cNADH dehydrogenase activity\u201d gene set members are shown in BT183, BT16, and D283. Proteasome regulatory particle proteins are highly abundant in BT183 compared to BT16 and D283. In contrast, NADH dehydrogenase activity proteins are significantly less abundant in BT183 compared to BT16 and D283. *** <em> P </em> &lt; 0.001. Welch\u2019s <em> t </em> -test. </p> </figcaption> </figure> </section> </section> <section id=\"s27\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"s27-anchor\"> </a> Discussion </h2> <p> The main ETMR-related novel findings of this report comprise (i) the close association of histomorphology and proteome signatures, (ii) an outline of tumor-specific molecular features depicted on different levels of gene expression regulation, (iii) an abundance of proteasome regulatory proteins, and (iv) the detection of proteasome inhibition as a promising therapeutic vulnerability. As embryonal brain tumors, especially ETMR, are quite rare, our study is limited by rather small case numbers. Consequently, not all molecular subtypes may be sufficiently represented in our series. For example, our series comprised only 2 non-C19MC-altered ETMR. </p> <p> Based on transcriptome data, Lambo et al. previously linked miRNA-related aberrations to R-loop-associated chromosomal instability with high DNA repair expression and helicase activity in ETMR. <sup> <a aria-describedby=\"CIT0006\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0006\"> 6 </a> </sup> As we also identified RNA processing mechanisms, gene silencing by miRNA, DNA repair, and helicase activity to be reflected on the proteome level, our study confirms these molecular features of ETMR. Roles of Hippo, NOTCH, WNT, and SHH signaling have also been described in ETMR. <sup> <a aria-describedby=\"CIT0006\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0006\"> 6 </a> , <a aria-describedby=\"CIT0035\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0035\"> 35 </a> </sup> Although several respective relevant gene set members were identified in our data, we could not confirm a significant enrichment of these pathways on the proteome level. However, statistical analyses revealed tendencies of enrichment, therefore these results might change with higher case numbers. Also, the reference samples used in this study may have affected the analytical results, since several subtypes of embryonal tumors rely on congruent pathway activations (e.g. SHH- and WNT-signaling in MB-SHH and MB-WNT, respectively). A recent study suggested that <em> C19MC </em> and LIN28A drive ETMR progression via a MYCN-mediated core transcriptional regulatory circuitry involving super-enhancer transcription factors. <sup> <a aria-describedby=\"CIT0036\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0036\"> 36 </a> </sup> Transcription factors are generally expressed with low abundancies and therefore, their detection is limited in proteome analyses. <sup> <a aria-describedby=\"CIT0037\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0037\"> 37 </a> </sup> Accordingly, major members of this transcriptional regulatory network such as MYCN, MAZ, SOX11, SALL1, and SP3 <sup> <a aria-describedby=\"CIT0036\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0036\"> 36 </a> </sup> were not detected in our analyses. </p> <p> We show that proteome signatures of ETMR are closely associated with histomorphological features. Previous studies have suggested a similar association between the ETMR transcriptome and histomorphology. In detail, transcriptional signatures related to DNA repair mechanisms were reported in ETMR rosettes whereas transcripts of astroglial differentiation were found in ETMR neuropil. <sup> <a aria-describedby=\"CIT0006\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0006\"> 6 </a> </sup> Although neuropil was characterized by a neuronal rather than an astroglial signature in our study, we generally confirm the close linkage of ETMR histomorphology and gene expression features. Importantly, distinctive markers of intratumoral heterogeneity showed similar expression patterns in the previously published transcriptome analyses of microdissected ETMR regions and our proteome analyses. </p> <p> Notably, transcriptomic subgroups relating to histomorphology have not been described in ETMR. In line with this, we detected no association of ETMR histological subtypes and clustering based on transcriptome profiles upon reviewing the annotations of the public data deposits used in this study. This may be because the entire tumor gives name to its histological variant, and analyzed specimens may not have been purposely compiled to representatively portray the histomorphology of the entire tumor. Moreover, the histological subtyping of ETMR may be subject to interobserver variability. </p> <p> The question arises as to whether the association of morphology and proteome signatures has clinical implications in ETMR. Previous studies demonstrated that overall survival times do not significantly differ between ETMR histological variants. <sup> <a aria-describedby=\"CIT0005\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0005\"> 5 </a> </sup> On the other hand, multiple reports have indicated a linkage between long-term survival and neuronal differentiation in some ETMR. <sup> <a aria-describedby=\"CIT0005\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0005\"> 5 </a> , <a aria-describedby=\"CIT0038\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0038\"> 38\u201340 </a> </sup> Thus, higher case numbers are needed to clarify if and how neuronal or histomorphology-associated proteome signatures may relate to better survival chances in ETMR. Moreover, differential proteomics associated with histomorphological variations between and within ETMR may warrant histology-oriented therapeutic approaches. For example, prevailingly undifferentiated tumors with EBL/MEPL-like morphology harbored DNA topoisomerases in abundance and may thus be more vulnerable towards treatment with anthracyclins. <sup> <a aria-describedby=\"CIT0041\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0041\"> 41 </a> </sup> On the other hand, neuropil-rich tumors showed upregulated synaptic signaling, which implies that antiepileptic drugs like levetiracetam may be beneficial as adjuvant cancer therapeutics in ETANTR and even exhibit antitumoral effects. <sup> <a aria-describedby=\"CIT0042\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0042\"> 42 </a> </sup> </p> <p> Since histomorphology-associated intratumoral proteome heterogeneity may facilitate tumor evolution under therapeutic selection pressure, we focused on pervasive proteome features of ETMR in this study. Among these features, we discovered understudied molecular characteristics of ETMR, which were not reflected in previously investigated levels of gene expression. For example, we discovered a low abundance of proteins involved in mitochondrial respiration in ETMR. Mitochondrial metabolism has been implicated in multi-functional roles in malignant tumor progression <sup> <a aria-describedby=\"CIT0043\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0043\"> 43 </a> , <a aria-describedby=\"CIT0044\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0044\"> 44 </a> </sup> and also is linked to sensitivity towards proteasome inhibition in cancers. <sup> <a aria-describedby=\"CIT0045\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0045\"> 45 </a> , <a aria-describedby=\"CIT0046\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0046\"> 46 </a> </sup> The roles of mitochondria for tumorigenesis and progression in ETMR are widely unknown. <sup> <a aria-describedby=\"CIT0047\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0047\"> 47 </a> </sup> </p> <p> The proteasome is an essential multi-subunit complex, which maintains proteostasis by degrading misfolded or damaged proteins. <sup> <a aria-describedby=\"CIT0048\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0048\"> 48 </a> , <a aria-describedby=\"CIT0049\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0049\"> 49 </a> </sup> Proteasome regulatory particles regulate the entry and delivery of proteins to the complex\u2019s catalytic core. <sup> <a aria-describedby=\"CIT0050\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0050\"> 50 </a> </sup> Previous studies have linked high levels of proteasome regulatory particles to cytotoxic sensitivity towards proteasome inhibition. <sup> <a aria-describedby=\"CIT0045\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0045\"> 45 </a> , <a aria-describedby=\"CIT0051\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0051\"> 51 </a> </sup> Proteasome regulatory particles were highly abundant in ETMR and BT183 cells, while in vitro assays demonstrated the vulnerability of ETMR cells toward proteasome inhibition using Marizomib. In line with our findings, a previous drug screen in BT183 tumor cells identified the proteasome-inhibitor Bortezomib as a potent in vitro ETMR drug candidate. <sup> <a aria-describedby=\"CIT0052\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0052\"> 52 </a> </sup> However, since Bortezomib does not cross the blood\u2013brain barrier, its clinical potential for ETMR treatment was not further pursued in vivo. <sup> <a aria-describedby=\"CIT0052\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0052\"> 52 </a> , <a aria-describedby=\"CIT0053\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0053\"> 53 </a> </sup> In recent years, the CNS penetrant proteasome-inhibitor Marizomib has gained attention in the treatment of hematopoietic and solid tumor models. <sup> <a aria-describedby=\"CIT0054\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0054\"> 54 </a> , <a aria-describedby=\"CIT0055\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0055\"> 55 </a> </sup> A previous drug screen by Lin et al. <sup> <a aria-describedby=\"CIT0056\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0056\"> 56 </a> </sup> identified the potential of Marizomib to treat cell culture models of diffuse midline glioma (DMG), H3K27 altered. Subsequently, a Phase I study was initiated to investigate Marizomib safety and preliminary efficacy in children with DMG ( <a class=\"usa-link\" href=\"https://clinicaltrials.gov/ct2/show/NCT04341311\" rel=\"noopener noreferrer\" target=\"_blank\"> NCT04341311 </a> ). A recently published report of this study proclaimed that children tolerated starting doses of Marizomib (0.6 mg/m\u00b2) without any dose-limiting toxicities or CNS toxicity. <sup> <a aria-describedby=\"CIT0057\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0057\"> 57 </a> </sup> Notably, Marizomib IC50s of the 6 DMG cell lines used in the study of Lin et al. <sup> <a aria-describedby=\"CIT0056\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0056\"> 56 </a> </sup> were in the range of 10\u2014100 nM and therefore comparable to BT183. Taken together, these results substantiate the therapeutic potential of proteasome inhibition and provide a rationale for future clinical trials to employ Marizomib in ETMR therapy. </p> </section> <section id=\"sec28\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"sec28-anchor\"> </a> Supplementary Material </h2> <section class=\"sm xbox font-sm\" id=\"sup1\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Figure_S1 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_figure_s1.jpeg\"> noad265_suppl_supplementary_figure_s1.jpeg </a> <sup> (5.8MB, jpeg) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"sup2\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Figure_S2 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_figure_s2.jpeg\"> noad265_suppl_supplementary_figure_s2.jpeg </a> <sup> (3MB, jpeg) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"sup3\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Figure_S3 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_figure_s3.jpeg\"> noad265_suppl_supplementary_figure_s3.jpeg </a> <sup> (2.3MB, jpeg) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"sup4\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Figure_S4 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_figure_s4.jpeg\"> noad265_suppl_supplementary_figure_s4.jpeg </a> <sup> (1.7MB, jpeg) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"sup5\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Figure_S5 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_figure_s5.jpeg\"> noad265_suppl_supplementary_figure_s5.jpeg </a> <sup> (3.3MB, jpeg) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"sup6\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Figure_S6 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_figure_s6.jpeg\"> noad265_suppl_supplementary_figure_s6.jpeg </a> <sup> (1.5MB, jpeg) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"sup7\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Figure_S7 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_figure_s7.jpeg\"> noad265_suppl_supplementary_figure_s7.jpeg </a> <sup> (4.4MB, jpeg) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"sup8\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Figure_S8 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_figure_s8.jpeg\"> noad265_suppl_supplementary_figure_s8.jpeg </a> <sup> (1.6MB, jpeg) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"sup9\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Table_S1 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_table_s1.xlsx\"> noad265_suppl_supplementary_table_s1.xlsx </a> <sup> (13.1KB, xlsx) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"sup10\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Table_S2 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_table_s2.xlsx\"> noad265_suppl_supplementary_table_s2.xlsx </a> <sup> (242.6KB, xlsx) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"sup11\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Table_S3 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_table_s3.xlsx\"> noad265_suppl_supplementary_table_s3.xlsx </a> <sup> (70.5KB, xlsx) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"sup12\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Table_S4 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_table_s4.xlsx\"> noad265_suppl_supplementary_table_s4.xlsx </a> <sup> (1.5MB, xlsx) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"sup13\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Table_S5 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_table_s5.xlsx\"> noad265_suppl_supplementary_table_s5.xlsx </a> <sup> (79.5KB, xlsx) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"sup14\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Table_S6 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_table_s6.xlsx\"> noad265_suppl_supplementary_table_s6.xlsx </a> <sup> (14KB, xlsx) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"sup15\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Table_S7 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_table_s7.xlsx\"> noad265_suppl_supplementary_table_s7.xlsx </a> <sup> (3.1MB, xlsx) </sup> </div> </div> </section> </section> <section class=\"ack\" id=\"a1\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"a1-anchor\"> </a> Acknowledgments </h2> <p> We thank the laboratory team of the Institute of Neuropathology (University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany): Celina Soltwedel, Carolina Janko, Ulrike Rumpf, Karin Gehlken, Ann-Kathleen Leptien, Helena Gladkov, and Nicole Borgardt for excellent technical support. We thank Ole Pless (Fraunhofer IME ScreeningPort, Hamburg, Germany) and Torben Hausrat (ZMNH, UKE, Hamburg, Germany) for helpful discussions. </p> </section> <section class=\"contrib-info\" id=\"_ci93_\" lang=\"en\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"_ci93_-anchor\"> </a> Contributor Information </h2> <p> Matthias Dottermusch, Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. </p> <p> Ali Biabani, Section of Mass Spectrometric Proteomics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. </p> <p> Tasja Lempertz, Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. </p> <p> Yannis Schumann, Chair for High Performance Computing, Helmut-Schmidt University, Hamburg, Germany. </p> <p> Jelena Navolic, Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. </p> <p> Shweta Godbole, Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. </p> <p> Denise Obrecht, Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. </p> <p> Stephan Frank, Division of Neuropathology, Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland. </p> <p> Mario M Dorostkar, Center for Neuropathology and Prion Research, Ludwig Maximilian University, Munich, Germany. </p> <p> Hannah Vo\u00df, Section of Mass Spectrometric Proteomics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. </p> <p> Hartmut Schl\u00fcter, Section of Mass Spectrometric Proteomics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. </p> <p> Stefan Rutkowski, Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. </p> <p> Ulrich Sch\u00fcller, Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Children\u2019s Cancer Research Center Hamburg, Hamburg, Germany. </p> <p> Julia E Neumann, Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. </p> </section> <section id=\"s29\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"s29-anchor\"> </a> Conflict of interest statement </h2> <p> None declared. </p> </section> <section id=\"s30\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"s30-anchor\"> </a> Funding </h2> <p> M.D. was supported by the Erich und Gertrud Roggenbuck-Stiftung. U.S. was supported by the F\u00f6rdergemeinschaft Kinderkrebszentrum Hamburg. J.E.N. was supported by the Deutsche Forschungsgemeinschaft (DFG, Emmy Noether programme), the Hamburger Krebsgesellschaft e.V., and the Erich und Gertrud Roggenbuck-Stiftung. </p> </section> <section id=\"s31\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"s31-anchor\"> </a> Author Contributions </h2> <p> M.D. and J.E.N. conceived the study. M.D., A.B., and T.L. performed experiments. M.D., A.B., T.L., Y.S., J.N., S.G., D.O., S.F., H.V., H.S., S.R., U.S., and J.E.N. analyzed and interpreted the data. M.D. drafted the manuscript. All authors provided critical feedback and helped shape the manuscript. </p> </section> <section class=\"ref-list\" id=\"r1\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"r1-anchor\"> </a> References </h2> <section id=\"r1_sec2\"> <ul class=\"ref-list font-sm\"> <li id=\"CIT0001\"> <span class=\"label\"> 1. </span> <cite> Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231\u20131251. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1093/neuonc/noab106\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC8328013/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/34185076/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&amp;title=The%202021%20WHO%20classification%20of%20tumors%20of%20the%20central%20nervous%20system:%20a%20summary&amp;volume=23&amp;issue=8&amp;publication_year=2021&amp;pages=1231-1251&amp;pmid=34185076&amp;doi=10.1093/neuonc/noab106&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0002\"> <span class=\"label\"> 2. </span> <cite> Lambo S, von Hoff K, Korshunov A, Pfister SM, Kool M.. ETMR: a tumor entity in its infancy. Acta Neuropathol 2020 1403. 2020;140(3):249\u2013266. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1007/s00401-020-02182-2\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC7423804/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/32601913/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathol%202020%201403.&amp;title=ETMR:%20a%20tumor%20entity%20in%20its%20infancy&amp;volume=140&amp;issue=3&amp;publication_year=2020&amp;pages=249-266&amp;pmid=32601913&amp;doi=10.1007/s00401-020-02182-2&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0003\"> <span class=\"label\"> 3. </span> <cite> Raghuram N, Khan S, Mumal I, Bouffet E, Huang A.. Embryonal tumors with multi-layered rosettes: a disease of dysregulated miRNAs. J Neurooncol. 2020;150(1):63\u201373. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1007/s11060-020-03633-2\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33090313/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=J%20Neurooncol.&amp;title=Embryonal%20tumors%20with%20multi-layered%20rosettes:%20a%20disease%20of%20dysregulated%20miRNAs&amp;volume=150&amp;issue=1&amp;publication_year=2020&amp;pages=63-73&amp;pmid=33090313&amp;doi=10.1007/s11060-020-03633-2&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0004\"> <span class=\"label\"> 4. </span> <cite> Woehrer A, Slavc I, Peyrl A, et al. Embryonal tumor with abundant neuropil and true rosettes (ETANTR) with loss of morphological but retained genetic key features during progression. Acta Neuropathol. 2011;122(6):787\u2013790. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1007/s00401-011-0903-2\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/22057788/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathol.&amp;title=Embryonal%20tumor%20with%20abundant%20neuropil%20and%20true%20rosettes%20(ETANTR)%20with%20loss%20of%20morphological%20but%20retained%20genetic%20key%20features%20during%20progression&amp;volume=122&amp;issue=6&amp;publication_year=2011&amp;pages=787-790&amp;pmid=22057788&amp;doi=10.1007/s00401-011-0903-2&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0005\"> <span class=\"label\"> 5. </span> <cite> Korshunov A, Sturm D, Ryzhova M, et al. Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathol. 2014;128(2):279\u2013289. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1007/s00401-013-1228-0\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC4102829/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/24337497/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathol.&amp;title=Embryonal%20tumor%20with%20abundant%20neuropil%20and%20true%20rosettes%20(ETANTR),%20ependymoblastoma,%20and%20medulloepithelioma%20share%20molecular%20similarity%20and%20comprise%20a%20single%20clinicopathological%20entity&amp;volume=128&amp;issue=2&amp;publication_year=2014&amp;pages=279-289&amp;pmid=24337497&amp;doi=10.1007/s00401-013-1228-0&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0006\"> <span class=\"label\"> 6. </span> <cite> Lambo S, Gr\u00f6bner SN, Rausch T, et al. The molecular landscape of ETMR at diagnosis and relapse. Nature. 2019;576(7786):274\u2013280. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/s41586-019-1815-x\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC6908757/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/31802000/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nature.&amp;title=The%20molecular%20landscape%20of%20ETMR%20at%20diagnosis%20and%20relapse&amp;volume=576&amp;issue=7786&amp;publication_year=2019&amp;pages=274-280&amp;pmid=31802000&amp;doi=10.1038/s41586-019-1815-x&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0007\"> <span class=\"label\"> 7. </span> <cite> Spence T, Sin-Chan P, Picard D, et al. CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathol. 2014;128(2):291\u2013303. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1007/s00401-014-1291-1\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC4159569/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/24839957/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathol.&amp;title=CNS-PNETs%20with%20C19MC%20amplification%20and/or%20LIN28%20expression%20comprise%20a%20distinct%20histogenetic%20diagnostic%20and%20therapeutic%20entity&amp;volume=128&amp;issue=2&amp;publication_year=2014&amp;pages=291-303&amp;pmid=24839957&amp;doi=10.1007/s00401-014-1291-1&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0008\"> <span class=\"label\"> 8. </span> <cite> Korshunov A, Remke M, Gessi M, et al. Focal genomic amplification at 19q1342 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes. Acta Neuropathol. 2010;120(2):253\u2013260. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1007/s00401-010-0688-8\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/20407781/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathol.&amp;title=Focal%20genomic%20amplification%20at%2019q1342%20comprises%20a%20powerful%20diagnostic%20marker%20for%20embryonal%20tumors%20with%20ependymoblastic%20rosettes&amp;volume=120&amp;issue=2&amp;publication_year=2010&amp;pages=253-260&amp;pmid=20407781&amp;doi=10.1007/s00401-010-0688-8&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0009\"> <span class=\"label\"> 9. </span> <cite> Uro-Coste E, Masliah-Planchon J, Siegfried A, et al. ETMR-like infantile cerebellar embryonal tumors in the extended morphologic spectrum of DICER1-related tumors. Acta Neuropathol. 2019;137(1):175\u2013177. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1007/s00401-018-1935-7\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/30446821/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathol.&amp;title=ETMR-like%20infantile%20cerebellar%20embryonal%20tumors%20in%20the%20extended%20morphologic%20spectrum%20of%20DICER1-related%20tumors&amp;volume=137&amp;issue=1&amp;publication_year=2019&amp;pages=175-177&amp;pmid=30446821&amp;doi=10.1007/s00401-018-1935-7&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0010\"> <span class=\"label\"> 10. </span> <cite> Vergani-Junior CA, Tonon-da-Silva G, Inan MD, Mori MA.. DICER: structure, function, and regulation. Biophys Rev. 2021;13(6):1081\u20131090. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1007/s12551-021-00902-w\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC8724510/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/35059029/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Biophys%20Rev.&amp;title=DICER:%20structure,%20function,%20and%20regulation&amp;volume=13&amp;issue=6&amp;publication_year=2021&amp;pages=1081-1090&amp;pmid=35059029&amp;doi=10.1007/s12551-021-00902-w&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0011\"> <span class=\"label\"> 11. </span> <cite> Juhnke BO, Gessi M, Gerber NU, et al. Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial. Neuro Oncol. 2022;24(1):127\u2013137. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1093/neuonc/noab100\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC8730753/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33908610/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&amp;title=Treatment%20of%20embryonal%20tumors%20with%20multilayered%20rosettes%20with%20carboplatin/etoposide%20induction%20and%20high-dose%20chemotherapy%20within%20the%20prospective%20P-HIT%20trial&amp;volume=24&amp;issue=1&amp;publication_year=2022&amp;pages=127-137&amp;pmid=33908610&amp;doi=10.1093/neuonc/noab100&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0012\"> <span class=\"label\"> 12. </span> <cite> Gupta K, Sood R, Salunke P, et al. Clinicopathological characteristics and outcomes in embryonal tumor with multilayered rosettes: A decade long experience from a tertiary care centre in North India. Ann Diagn Pathol. 2021;53(August2021):151745. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.anndiagpath.2021.151745\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33964610/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Ann%20Diagn%20Pathol.&amp;title=Clinicopathological%20characteristics%20and%20outcomes%20in%20embryonal%20tumor%20with%20multilayered%20rosettes:%20A%20decade%20long%20experience%20from%20a%20tertiary%20care%20centre%20in%20North%20India&amp;volume=53&amp;issue=August2021&amp;publication_year=2021&amp;pages=151745&amp;pmid=33964610&amp;doi=10.1016/j.anndiagpath.2021.151745&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0013\"> <span class=\"label\"> 13. </span> <cite> Hughes CS, Moggridge S, M\u00fcller T, et al. Single-pot, solid-phase-enhanced sample preparation for proteomics experiments. Nat Protoc 2018 141. 2018;14(1):68\u201385. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/s41596-018-0082-x\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/30464214/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nat%20Protoc%202018%20141.&amp;title=Single-pot,%20solid-phase-enhanced%20sample%20preparation%20for%20proteomics%20experiments&amp;volume=14&amp;issue=1&amp;publication_year=2018&amp;pages=68-85&amp;pmid=30464214&amp;doi=10.1038/s41596-018-0082-x&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0014\"> <span class=\"label\"> 14. </span> <cite> Kool M, Koster J, Bunt J, et al. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One. 2008;3(8):e3088. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1371/journal.pone.0003088\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC2518524/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/18769486/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=PLoS%20One.&amp;title=Integrated%20genomics%20identifies%20five%20medulloblastoma%20subtypes%20with%20distinct%20genetic%20profiles,%20pathway%20signatures%20and%20clinicopathological%20features&amp;volume=3&amp;issue=8&amp;publication_year=2008&amp;pages=e3088&amp;pmid=18769486&amp;doi=10.1371/journal.pone.0003088&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0015\"> <span class=\"label\"> 15. </span> <cite> Johann PD, Erkek S, Zapatka M, et al. Atypical teratoid/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes. Cancer Cell. 2016;29(3):379\u2013393. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.ccell.2016.02.001\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/26923874/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Atypical%20teratoid/rhabdoid%20tumors%20are%20comprised%20of%20three%20epigenetic%20subgroups%20with%20distinct%20enhancer%20landscapes&amp;volume=29&amp;issue=3&amp;publication_year=2016&amp;pages=379-393&amp;pmid=26923874&amp;doi=10.1016/j.ccell.2016.02.001&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0016\"> <span class=\"label\"> 16. </span> <cite> Sturm D, Orr BA, Toprak UH, et al. New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell. 2016;164(5):1060\u20131072. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.cell.2016.01.015\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC5139621/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/26919435/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Cell.&amp;title=New%20brain%20tumor%20entities%20emerge%20from%20molecular%20classification%20of%20CNS-PNETs&amp;volume=164&amp;issue=5&amp;publication_year=2016&amp;pages=1060-1072&amp;pmid=26919435&amp;doi=10.1016/j.cell.2016.01.015&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0017\"> <span class=\"label\"> 17. </span> <cite> Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201315550. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1073/pnas.0506580102\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC1239896/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/16199517/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A.&amp;title=Gene%20set%20enrichment%20analysis:%20a%20knowledge-based%20approach%20for%20interpreting%20genome-wide%20expression%20profiles&amp;volume=102&amp;issue=43&amp;publication_year=2005&amp;pages=15545-15550&amp;pmid=16199517&amp;doi=10.1073/pnas.0506580102&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0018\"> <span class=\"label\"> 18. </span> <cite> Aryee MJ, Jaffe AE, Corrada-Bravo H, et al. Minfi: a flexible and comprehensive bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30(10):1363\u20131369. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1093/bioinformatics/btu049\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC4016708/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/24478339/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Bioinformatics.&amp;title=Minfi:%20a%20flexible%20and%20comprehensive%20bioconductor%20package%20for%20the%20analysis%20of%20Infinium%20DNA%20methylation%20microarrays&amp;volume=30&amp;issue=10&amp;publication_year=2014&amp;pages=1363-1369&amp;pmid=24478339&amp;doi=10.1093/bioinformatics/btu049&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0019\"> <span class=\"label\"> 19. </span> <cite> R Core Team. R: A Language and Environment for Statistical Computing. 2020. <a class=\"usa-link usa-link--external\" href=\"https://www.r-project.org/\" rel=\"noopener noreferrer\" target=\"_blank\"> https://www.r-project.org/ </a> </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?title=R:%20A%20Language%20and%20Environment%20for%20Statistical%20Computing&amp;publication_year=2020&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0020\"> <span class=\"label\"> 20. </span> <cite> Tian Y, Morris TJ, Webster AP, et al. ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics. 2017;33(24):3982\u20133984. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1093/bioinformatics/btx513\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC5860089/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/28961746/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Bioinformatics.&amp;title=ChAMP:%20updated%20methylation%20analysis%20pipeline%20for%20Illumina%20BeadChips&amp;volume=33&amp;issue=24&amp;publication_year=2017&amp;pages=3982-3984&amp;pmid=28961746&amp;doi=10.1093/bioinformatics/btx513&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0021\"> <span class=\"label\"> 21. </span> <cite> Petralia F, Tignor N, Reva B, et al. ; Children\u2019s Brain Tumor Network. Integrated proteogenomic characterization across major histological types of pediatric brain Cancer. Cell. 2020;183(7):1962\u20131985.e31. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.cell.2020.10.044\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC8143193/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33242424/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Cell.&amp;title=Integrated%20proteogenomic%20characterization%20across%20major%20histological%20types%20of%20pediatric%20brain%20Cancer&amp;volume=183&amp;issue=7&amp;publication_year=2020&amp;pages=1962-1985.e31&amp;pmid=33242424&amp;doi=10.1016/j.cell.2020.10.044&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0022\"> <span class=\"label\"> 22. </span> <cite> Johnson WE, Li C, Rabinovic A.. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118\u2013127. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1093/biostatistics/kxj037\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/16632515/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Biostatistics&amp;title=Adjusting%20batch%20effects%20in%20microarray%20expression%20data%20using%20empirical%20Bayes%20methods&amp;volume=8&amp;issue=1&amp;publication_year=2007&amp;pages=118-127&amp;pmid=16632515&amp;doi=10.1093/biostatistics/kxj037&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0023\"> <span class=\"label\"> 23. </span> <cite> Sweeney TE, Wong HR, Khatri P.. Robust classification of bacterial and viral infections via integrated host gene expression diagnostics. Sci Transl Med. 2016;8(346):346ra91. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1126/scitranslmed.aaf7165\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC5348917/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/27384347/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Sci%20Transl%20Med.&amp;title=Robust%20classification%20of%20bacterial%20and%20viral%20infections%20via%20integrated%20host%20gene%20expression%20diagnostics&amp;volume=8&amp;issue=346&amp;publication_year=2016&amp;pages=346ra91&amp;pmid=27384347&amp;doi=10.1126/scitranslmed.aaf7165&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0024\"> <span class=\"label\"> 24. </span> <cite> Wu T, Hu E, Xu S, et al. clusterProfiler 40: A universal enrichment tool for interpreting omics data. Innovation. 2021;2(3):100141. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.xinn.2021.100141\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC8454663/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/34557778/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Innovation&amp;title=clusterProfiler%2040:%20A%20universal%20enrichment%20tool%20for%20interpreting%20omics%20data&amp;volume=2&amp;issue=3&amp;publication_year=2021&amp;pages=100141&amp;pmid=34557778&amp;doi=10.1016/j.xinn.2021.100141&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0025\"> <span class=\"label\"> 25. </span> <cite> H\u00e4nzelmann S, Castelo R, Guinney J.. GSVA: Gene set variation analysis for microarray and RNA-Seq data. BMC Bioinf. 2013;14(1):1\u201315. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1186/1471-2105-14-7\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC3618321/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/23323831/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=BMC%20Bioinf.&amp;title=GSVA:%20Gene%20set%20variation%20analysis%20for%20microarray%20and%20RNA-Seq%20data&amp;volume=14&amp;issue=1&amp;publication_year=2013&amp;pages=1-15&amp;pmid=23323831&amp;doi=10.1186/1471-2105-14-7&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0026\"> <span class=\"label\"> 26. </span> <cite> Gaujoux R, Seoighe C.. A flexible R package for nonnegative matrix factorization. BMC Bioinf. 2010;11(1):1\u20139. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1186/1471-2105-11-367\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC2912887/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/20598126/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=BMC%20Bioinf.&amp;title=A%20flexible%20R%20package%20for%20nonnegative%20matrix%20factorization&amp;volume=11&amp;issue=1&amp;publication_year=2010&amp;pages=1-9&amp;pmid=20598126&amp;doi=10.1186/1471-2105-11-367&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0027\"> <span class=\"label\"> 27. </span> <cite> Kr\u00e4mer A, Green J, Pollard J, Tugendreich S.. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics. 2014;30(4):523\u2013530. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1093/bioinformatics/btt703\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC3928520/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/24336805/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Bioinformatics.&amp;title=Causal%20analysis%20approaches%20in%20ingenuity%20pathway%20analysis&amp;volume=30&amp;issue=4&amp;publication_year=2014&amp;pages=523-530&amp;pmid=24336805&amp;doi=10.1093/bioinformatics/btt703&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0028\"> <span class=\"label\"> 28. </span> <cite> Perez-Riverol Y, Bai J, Bandla C, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50(D1):D543\u2013D552. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1093/nar/gkab1038\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC8728295/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/34723319/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=The%20PRIDE%20database%20resources%20in%202022:%20a%20hub%20for%20mass%20spectrometry-based%20proteomics%20evidences&amp;volume=50&amp;issue=D1&amp;publication_year=2022&amp;pages=D543-D552&amp;pmid=34723319&amp;doi=10.1093/nar/gkab1038&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0029\"> <span class=\"label\"> 29. </span> <cite> Capper D, Jones DTW, Sill M, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555(7697):469\u2013474. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/nature26000\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC6093218/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/29539639/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nature.&amp;title=DNA%20methylation-based%20classification%20of%20central%20nervous%20system%20tumours&amp;volume=555&amp;issue=7697&amp;publication_year=2018&amp;pages=469-474&amp;pmid=29539639&amp;doi=10.1038/nature26000&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0030\"> <span class=\"label\"> 30. </span> <cite> Zin F, Cotter JA, Haberler C, et al. Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup. Brain Pathol. 2021;31(5):12967. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1111/bpa.12967\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC8412123/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33938067/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Brain%20Pathol.&amp;title=Histopathological%20patterns%20in%20atypical%20teratoid/rhabdoid%20tumors%20are%20related%20to%20molecular%20subgroup&amp;volume=31&amp;issue=5&amp;publication_year=2021&amp;pages=12967&amp;pmid=33938067&amp;doi=10.1111/bpa.12967&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0031\"> <span class=\"label\"> 31. </span> <cite> Eberhart CG, Kepner JL, Goldthwaite PT, et al. Histopathologic grading of medulloblastomas. Cancer. 2002;94(2):552\u2013560. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1002/cncr.10189\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/11900240/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Cancer.&amp;title=Histopathologic%20grading%20of%20medulloblastomas&amp;volume=94&amp;issue=2&amp;publication_year=2002&amp;pages=552-560&amp;pmid=11900240&amp;doi=10.1002/cncr.10189&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0032\"> <span class=\"label\"> 32. </span> <cite> Ram\u00f3n y Cajal S, Ses\u00e9 M, Capdevila C, et al. Clinical implications of intratumor heterogeneity: challenges and opportunities. J Mol Med (Berl). 2020;98(2):161\u2013177. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1007/s00109-020-01874-2\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC7007907/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/31970428/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=J%20Mol%20Med%20(Berl).&amp;title=Clinical%20implications%20of%20intratumor%20heterogeneity:%20challenges%20and%20opportunities&amp;volume=98&amp;issue=2&amp;publication_year=2020&amp;pages=161-177&amp;pmid=31970428&amp;doi=10.1007/s00109-020-01874-2&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0033\"> <span class=\"label\"> 33. </span> <cite> Hesham D, El-Naggar S.. Transcriptomic analysis revealed an emerging role of alternative splicing in embryonal tumor with multilayered rosettes. Genes (Basel). 2020;11(9):1108\u20131111. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.3390/genes11091108\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC7563716/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/32971786/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Genes%20(Basel)&amp;title=Transcriptomic%20analysis%20revealed%20an%20emerging%20role%20of%20alternative%20splicing%20in%20embryonal%20tumor%20with%20multilayered%20rosettes&amp;volume=11&amp;issue=9&amp;publication_year=2020&amp;pages=1108-1111&amp;pmid=32971786&amp;doi=10.3390/genes11091108&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0034\"> <span class=\"label\"> 34. </span> <cite> Spence T, Perotti C, Sin-Chan P, et al. A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes. Neuro Oncol. 2014;16(1):62\u201371. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1093/neuonc/not162\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC3870842/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/24311633/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&amp;title=A%20novel%20C19MC%20amplified%20cell%20line%20links%20Lin28/let-7%20to%20mTOR%20signaling%20in%20embryonal%20tumor%20with%20multilayered%20rosettes&amp;volume=16&amp;issue=1&amp;publication_year=2014&amp;pages=62-71&amp;pmid=24311633&amp;doi=10.1093/neuonc/not162&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0035\"> <span class=\"label\"> 35. </span> <cite> Neumann JE, Wefers AK, Lambo S, et al. A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitors. Nat Med. 2017;23(10):1191\u20131202. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/nm.4402\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/28892064/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Nat%20Med.&amp;title=A%20mouse%20model%20for%20embryonal%20tumors%20with%20multilayered%20rosettes%20uncovers%20the%20therapeutic%20potential%20of%20Sonic-hedgehog%20inhibitors&amp;volume=23&amp;issue=10&amp;publication_year=2017&amp;pages=1191-1202&amp;pmid=28892064&amp;doi=10.1038/nm.4402&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0036\"> <span class=\"label\"> 36. </span> <cite> Sin-Chan P, Mumal I, Suwal T, et al. A C19MC-LIN28A-MYCN oncogenic circuit driven by hijacked super-enhancers is a distinct therapeutic vulnerability in ETMRs: a Lethal Brain Tumor. Cancer Cell. 2019;36(1):51\u201367.e7. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.ccell.2019.06.002\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/31287992/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=A%20C19MC-LIN28A-MYCN%20oncogenic%20circuit%20driven%20by%20hijacked%20super-enhancers%20is%20a%20distinct%20therapeutic%20vulnerability%20in%20ETMRs:%20a%20Lethal%20Brain%20Tumor&amp;volume=36&amp;issue=1&amp;publication_year=2019&amp;pages=51-67.e7&amp;pmid=31287992&amp;doi=10.1016/j.ccell.2019.06.002&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0037\"> <span class=\"label\"> 37. </span> <cite> Simicevic J, Deplancke B.. Transcription factor proteomics\u2014tools, applications, and challenges. Proteomics. 2017;17(3-4):1600317. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1002/pmic.201600317\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/27860250/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Proteomics&amp;title=Transcription%20factor%20proteomics%E2%80%94tools,%20applications,%20and%20challenges&amp;volume=17&amp;issue=3-4&amp;publication_year=2017&amp;pages=1600317&amp;pmid=27860250&amp;doi=10.1002/pmic.201600317&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0038\"> <span class=\"label\"> 38. </span> <cite> Gualano FM, Hassoun P, Carter CL, Hanson D.. Embryonal tumor with multilayered rosettes: post-treatment maturation and implications for future therapy. Cancer reports (Hoboken, NJ). 2023;6(5):e1812. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1002/cnr2.1812\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC10172162/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/36965133/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Cancer%20reports%20(Hoboken,%20NJ)&amp;title=Embryonal%20tumor%20with%20multilayered%20rosettes:%20post-treatment%20maturation%20and%20implications%20for%20future%20therapy&amp;volume=6&amp;issue=5&amp;publication_year=2023&amp;pages=e1812&amp;pmid=36965133&amp;doi=10.1002/cnr2.1812&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0039\"> <span class=\"label\"> 39. </span> <cite> Antonelli M, Korshunov A, Mastronuzzi A, et al. Long-term survival in a case of ETANTR with histological features of neuronal maturation after therapy. Virchows Arch. 2015;466(5):603\u2013607. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1007/s00428-015-1736-5\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/25697539/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Virchows%20Arch.&amp;title=Long-term%20survival%20in%20a%20case%20of%20ETANTR%20with%20histological%20features%20of%20neuronal%20maturation%20after%20therapy&amp;volume=466&amp;issue=5&amp;publication_year=2015&amp;pages=603-607&amp;pmid=25697539&amp;doi=10.1007/s00428-015-1736-5&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0040\"> <span class=\"label\"> 40. </span> <cite> Jaramillo S, Grosshans DR, Philip N, et al. Radiation for ETMR: literature review and case series of patients treated with proton therapy. Clin Transl Radiat Oncol. 2019;15(February2019):31\u201337. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.ctro.2018.11.002\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC6297264/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/30582019/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Clin%20Transl%20Radiat%20Oncol&amp;title=Radiation%20for%20ETMR:%20literature%20review%20and%20case%20series%20of%20patients%20treated%20with%20proton%20therapy&amp;volume=15&amp;issue=February2019&amp;publication_year=2019&amp;pages=31-37&amp;pmid=30582019&amp;doi=10.1016/j.ctro.2018.11.002&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0041\"> <span class=\"label\"> 41. </span> <cite> Ros M, Iorio AL, Lucchesi M, et al. The use of anthracyclines for therapy of CNS tumors. Anticancer Agents Med Chem. 2015;15(6):721. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.2174/1871520615666150407155319\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC4997942/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/25846760/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Anticancer%20Agents%20Med%20Chem.&amp;title=The%20use%20of%20anthracyclines%20for%20therapy%20of%20CNS%20tumors&amp;volume=15&amp;issue=6&amp;publication_year=2015&amp;pages=721&amp;pmid=25846760&amp;doi=10.2174/1871520615666150407155319&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0042\"> <span class=\"label\"> 42. </span> <cite> Cucchiara F, Pasqualetti F, Giorgi FS, Danesi R, Bocci G.. Epileptogenesis and oncogenesis: an antineoplastic role for antiepileptic drugs in brain tumours? Pharmacol Res. 2020;156(June2020):104786. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.phrs.2020.104786\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/32278037/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Pharmacol%20Res.&amp;title=Epileptogenesis%20and%20oncogenesis:%20an%20antineoplastic%20role%20for%20antiepileptic%20drugs%20in%20brain%20tumours&amp;volume=156&amp;issue=June2020&amp;publication_year=2020&amp;pages=104786&amp;pmid=32278037&amp;doi=10.1016/j.phrs.2020.104786&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0043\"> <span class=\"label\"> 43. </span> <cite> Zong WX, Rabinowitz JD, White E.. Mitochondria and cancer. Mol Cell. 2016;61(5):667\u2013676. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.molcel.2016.02.011\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC4779192/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/26942671/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Mol%20Cell.&amp;title=Mitochondria%20and%20cancer&amp;volume=61&amp;issue=5&amp;publication_year=2016&amp;pages=667-676&amp;pmid=26942671&amp;doi=10.1016/j.molcel.2016.02.011&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0044\"> <span class=\"label\"> 44. </span> <cite> Klein K, He K, Younes AI, et al. Role of mitochondria in cancer immune evasion and potential therapeutic approaches. Front Immunol. 2020;11(October2020):573326. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.3389/fimmu.2020.573326\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC7596324/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33178201/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Front%20Immunol.&amp;title=Role%20of%20mitochondria%20in%20cancer%20immune%20evasion%20and%20potential%20therapeutic%20approaches&amp;volume=11&amp;issue=October2020&amp;publication_year=2020&amp;pages=573326&amp;pmid=33178201&amp;doi=10.3389/fimmu.2020.573326&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0045\"> <span class=\"label\"> 45. </span> <cite> Tsvetkov P, Mendillo ML, Zhao J, et al. Compromising the 19S proteasome complex protects cells from reduced flux through the proteasome. Elife. 2015;4(September2015):e08467. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.7554/eLife.08467\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC4551903/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/26327695/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Elife&amp;title=Compromising%20the%2019S%20proteasome%20complex%20protects%20cells%20from%20reduced%20flux%20through%20the%20proteasome&amp;volume=4&amp;issue=September2015&amp;publication_year=2015&amp;pages=e08467&amp;pmid=26327695&amp;doi=10.7554/eLife.08467&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0046\"> <span class=\"label\"> 46. </span> <cite> Soriano GP, Besse L, Li N, et al. Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism. Leukemia. 2016;30(11):2198\u20132207. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1038/leu.2016.102\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC5097071/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/27118406/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Leukemia.&amp;title=Proteasome%20inhibitor-adapted%20myeloma%20cells%20are%20largely%20independent%20from%20proteasome%20activity%20and%20show%20complex%20proteomic%20changes,%20in%20particular%20in%20redox%20and%20energy%20metabolism&amp;volume=30&amp;issue=11&amp;publication_year=2016&amp;pages=2198-2207&amp;pmid=27118406&amp;doi=10.1038/leu.2016.102&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0047\"> <span class=\"label\"> 47. </span> <cite> Liapis E, Pamreddy A, Maas A, Hanson D, Carter C.. Atrt-14 assessment of mitochondrial bioenergetics and fission-fusion dynamics in ETMR. Neuro Oncol. 2023;25(Supplement_1):i4. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&amp;title=Atrt-14%20assessment%20of%20mitochondrial%20bioenergetics%20and%20fission-fusion%20dynamics%20in%20ETMR&amp;volume=25&amp;issue=Supplement_1&amp;publication_year=2023&amp;pages=i4&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0048\"> <span class=\"label\"> 48. </span> <cite> T\u00fcrker F, Cook EK, Margolis SS.. The proteasome and its role in the nervous system. Cell Chem Biol. 2021;28(7):903\u2013917. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.chembiol.2021.04.003\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC8286317/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/33905676/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Cell%20Chem%20Biol&amp;title=The%20proteasome%20and%20its%20role%20in%20the%20nervous%20system&amp;volume=28&amp;issue=7&amp;publication_year=2021&amp;pages=903-917&amp;pmid=33905676&amp;doi=10.1016/j.chembiol.2021.04.003&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0049\"> <span class=\"label\"> 49. </span> <cite> Kamber Kaya HE, Radhakrishnan SK.. Trash talk: mammalian proteasome regulation at the transcriptional level. Trends Genet. 2021;37(2):160\u2013173. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1016/j.tig.2020.09.005\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC7856062/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/32988635/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Trends%20Genet.&amp;title=Trash%20talk:%20mammalian%20proteasome%20regulation%20at%20the%20transcriptional%20level&amp;volume=37&amp;issue=2&amp;publication_year=2021&amp;pages=160-173&amp;pmid=32988635&amp;doi=10.1016/j.tig.2020.09.005&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0050\"> <span class=\"label\"> 50. </span> <cite> Tanaka K, Mizushima T, Saeki Y.. The proteasome: molecular machinery and pathophysiological roles. Biol Chem. 2012;393(4):217\u2013234. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1515/hsz-2011-0285\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/23029643/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Biol%20Chem.&amp;title=The%20proteasome:%20molecular%20machinery%20and%20pathophysiological%20roles&amp;volume=393&amp;issue=4&amp;publication_year=2012&amp;pages=217-234&amp;pmid=23029643&amp;doi=10.1515/hsz-2011-0285&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0051\"> <span class=\"label\"> 51. </span> <cite> Acosta-Alvear D, Cho MY, Wild T, et al. Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits. Elife. 2015;4(September):e08153. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.7554/eLife.08153\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC4602331/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/26327694/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Elife&amp;title=Paradoxical%20resistance%20of%20multiple%20myeloma%20to%20proteasome%20inhibitors%20by%20decreased%20levels%20of%2019S%20proteasomal%20subunits&amp;volume=4&amp;issue=September&amp;publication_year=2015&amp;pages=e08153&amp;pmid=26327694&amp;doi=10.7554/eLife.08153&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0052\"> <span class=\"label\"> 52. </span> <cite> Schmidt C, Schubert NA, Brabetz S, et al. Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients. Neuro Oncol. 2017;19(12):1607\u20131617. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1093/neuonc/nox093\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC5716199/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/28482026/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&amp;title=Preclinical%20drug%20screen%20reveals%20topotecan,%20actinomycin%20D,%20and%20volasertib%20as%20potential%20new%20therapeutic%20candidates%20for%20ETMR%20brain%20tumor%20patients&amp;volume=19&amp;issue=12&amp;publication_year=2017&amp;pages=1607-1617&amp;pmid=28482026&amp;doi=10.1093/neuonc/nox093&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0053\"> <span class=\"label\"> 53. </span> <cite> Huehnchen P, Springer A, Kern J, et al. Bortezomib at therapeutic doses poorly passes the blood-brain barrier and does not impair cognition. Brain Commun. 2020;2(1):fcaa021. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1093/braincomms/fcaa021\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC7425526/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/32954282/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Brain%20Commun&amp;title=Bortezomib%20at%20therapeutic%20doses%20poorly%20passes%20the%20blood-brain%20barrier%20and%20does%20not%20impair%20cognition&amp;volume=2&amp;issue=1&amp;publication_year=2020&amp;pages=fcaa021&amp;pmid=32954282&amp;doi=10.1093/braincomms/fcaa021&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0054\"> <span class=\"label\"> 54. </span> <cite> Seyed MA, Ayesha S.. Marine-derived pipeline anticancer natural products: a review of their pharmacotherapeutic potential and molecular mechanisms. Futur J Pharm Sci 2021 71. 2021;7(1):1\u201314. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Futur%20J%20Pharm%20Sci%202021%2071.&amp;title=Marine-derived%20pipeline%20anticancer%20natural%20products:%20a%20review%20of%20their%20pharmacotherapeutic%20potential%20and%20molecular%20mechanisms&amp;volume=7&amp;issue=1&amp;publication_year=2021&amp;pages=1-14&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0055\"> <span class=\"label\"> 55. </span> <cite> Di K, Lloyd GK, Abraham V, et al. Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier. Neuro Oncol. 2016;18(6):840\u2013848. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1093/neuonc/nov299\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC4864261/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/26681765/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&amp;title=Marizomib%20activity%20as%20a%20single%20agent%20in%20malignant%20gliomas:%20ability%20to%20cross%20the%20blood-brain%20barrier&amp;volume=18&amp;issue=6&amp;publication_year=2016&amp;pages=840-848&amp;pmid=26681765&amp;doi=10.1093/neuonc/nov299&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0056\"> <span class=\"label\"> 56. </span> <cite> Lin GL, Wilson KM, Ceribelli M, et al. Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening. Sci Transl Med. 2019;11(519):eaaw0064. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://doi.org/10.1126/scitranslmed.aaw0064\" rel=\"noopener noreferrer\" target=\"_blank\"> DOI </a> ] [ <a class=\"usa-link\" href=\"/articles/PMC7132630/\"> PMC free article </a> ] [ <a class=\"usa-link\" href=\"https://pubmed.ncbi.nlm.nih.gov/31748226/\"> PubMed </a> ] [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Sci%20Transl%20Med.&amp;title=Therapeutic%20strategies%20for%20diffuse%20midline%20glioma%20from%20high-throughput%20combination%20drug%20screening&amp;volume=11&amp;issue=519&amp;publication_year=2019&amp;pages=eaaw0064&amp;pmid=31748226&amp;doi=10.1126/scitranslmed.aaw0064&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> <li id=\"CIT0057\"> <span class=\"label\"> 57. </span> <cite> Warren KE, Greenspan L, Strachan M, et al. P1184A phase 1 trial of marizomib alone and in combination with panobinostat in children with diffuse intrinsic pontine glioma (DIPG). Neuro-Oncology. 2023;25(Supplement_2):ii95\u2013ii96. </cite> [ <a class=\"usa-link usa-link--external\" href=\"https://scholar.google.com/scholar_lookup?journal=Neuro-Oncology&amp;title=P1184A%20phase%201%20trial%20of%20marizomib%20alone%20and%20in%20combination%20with%20panobinostat%20in%20children%20with%20diffuse%20intrinsic%20pontine%20glioma%20(DIPG)&amp;volume=25&amp;issue=Supplement_2&amp;publication_year=2023&amp;pages=ii95-ii96&amp;\" rel=\"noopener noreferrer\" target=\"_blank\"> Google Scholar </a> ] </li> </ul> </section> </section> <section class=\"associated-data\" id=\"_ad93_\" lang=\"en\"> <h2 class=\"pmc_sec_title\"> <a class=\"usa-anchor\" id=\"_ad93_-anchor\"> </a> Associated Data </h2> <p class=\"font-secondary\"> <em> This section collects any data citations, data availability statements, or supplementary materials included in this article. </em> </p> <section class=\"supplementary-materials\" id=\"_adsm93_\" lang=\"en\"> <h3 class=\"pmc_sec_title\"> Supplementary Materials </h3> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material1_reqid_\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Figure_S1 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_figure_s1.jpeg\"> noad265_suppl_supplementary_figure_s1.jpeg </a> <sup> (5.8MB, jpeg) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material2_reqid_\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Figure_S2 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_figure_s2.jpeg\"> noad265_suppl_supplementary_figure_s2.jpeg </a> <sup> (3MB, jpeg) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material3_reqid_\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Figure_S3 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_figure_s3.jpeg\"> noad265_suppl_supplementary_figure_s3.jpeg </a> <sup> (2.3MB, jpeg) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material4_reqid_\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Figure_S4 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_figure_s4.jpeg\"> noad265_suppl_supplementary_figure_s4.jpeg </a> <sup> (1.7MB, jpeg) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material5_reqid_\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Figure_S5 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_figure_s5.jpeg\"> noad265_suppl_supplementary_figure_s5.jpeg </a> <sup> (3.3MB, jpeg) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material6_reqid_\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Figure_S6 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_figure_s6.jpeg\"> noad265_suppl_supplementary_figure_s6.jpeg </a> <sup> (1.5MB, jpeg) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material7_reqid_\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Figure_S7 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_figure_s7.jpeg\"> noad265_suppl_supplementary_figure_s7.jpeg </a> <sup> (4.4MB, jpeg) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material8_reqid_\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Figure_S8 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_figure_s8.jpeg\"> noad265_suppl_supplementary_figure_s8.jpeg </a> <sup> (1.6MB, jpeg) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material9_reqid_\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Table_S1 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_table_s1.xlsx\"> noad265_suppl_supplementary_table_s1.xlsx </a> <sup> (13.1KB, xlsx) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material10_reqid_\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Table_S2 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_table_s2.xlsx\"> noad265_suppl_supplementary_table_s2.xlsx </a> <sup> (242.6KB, xlsx) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material11_reqid_\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Table_S3 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_table_s3.xlsx\"> noad265_suppl_supplementary_table_s3.xlsx </a> <sup> (70.5KB, xlsx) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material12_reqid_\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Table_S4 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_table_s4.xlsx\"> noad265_suppl_supplementary_table_s4.xlsx </a> <sup> (1.5MB, xlsx) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material13_reqid_\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Table_S5 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_table_s5.xlsx\"> noad265_suppl_supplementary_table_s5.xlsx </a> <sup> (79.5KB, xlsx) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material14_reqid_\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Table_S6 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_table_s6.xlsx\"> noad265_suppl_supplementary_table_s6.xlsx </a> <sup> (14KB, xlsx) </sup> </div> </div> </section> <section class=\"sm xbox font-sm\" id=\"db_ds_supplementary-material15_reqid_\"> <div class=\"caption p\"> <span> noad265_suppl_Supplementary_Table_S7 </span> </div> <div class=\"media p\"> <div class=\"caption\"> <a class=\"usa-link\" href=\"/articles/instance/11066909/bin/noad265_suppl_supplementary_table_s7.xlsx\"> noad265_suppl_supplementary_table_s7.xlsx </a> <sup> (3.1MB, xlsx) </sup> </div> </div> </section> </section> <section class=\"data-availability-statement\" id=\"_adda93_\" lang=\"en\"> <h3 class=\"pmc_sec_title\"> Data Availability Statement </h3> <p> The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE <sup> <a aria-describedby=\"CIT0028\" aria-expanded=\"false\" class=\"usa-link\" href=\"#CIT0028\"> 28 </a> </sup> partner repository with the dataset identifier PXD045268. </p> </section> </section> </section> <footer class=\"p courtesy-note font-secondary font-sm text-center\"> <hr class=\"headless\"/> <p> Articles from Neuro-Oncology are provided here courtesy of <strong> Society for Neuro-Oncology and Oxford University Press </strong> </p> </footer> </section> </article> </main> </div> </div> </div> <div class=\"pmc-sidenav desktop:grid-col-4 display-flex\"> <section aria-label=\"Article resources and navigation\" class=\"pmc-sidenav__container\"> <button class=\"usa-button pmc-sidenav__container__close usa-button--unstyled\" type=\"button\"> <img alt=\"Close\" role=\"img\" src=\"/static/img/usa-icons/close.svg\"/> </button> <div class=\"display-none desktop:display-block\"> <section class=\"margin-top-4 desktop:margin-top-0\"> <h2 class=\"margin-top-0\"> ACTIONS </h2> <ul class=\"usa-list usa-list--unstyled usa-list--actions\"> <li> <a class=\"usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1\" href=\"https://doi.org/10.1093/neuonc/noad265\" rel=\"noreferrer noopener\" target=\"_blank\"> <svg aria-hidden=\"true\" class=\"usa-icon width-3 height-3\" focusable=\"false\" hidden=\"\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#launch\"> </use> </svg> <span class=\"display-inline-flex flex-justify-center flex-1 padding-right-2\"> View on publisher site </span> </a> </li> <li> <a class=\"usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1\" href=\"pdf/noad265.pdf\"> <svg aria-hidden=\"true\" class=\"usa-icon width-3 height-3\" focusable=\"false\" hidden=\"\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#file_download\"> </use> </svg> <span class=\"display-inline-flex flex-justify-center flex-1\"> PDF (30.8 MB) </span> </a> </li> <li> <button aria-label=\"Open dialog with citation text in different styles\" class=\"usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1\" role=\"button\"> <svg aria-hidden=\"true\" class=\"usa-icon width-3 height-3\" focusable=\"false\" hidden=\"\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#format_quote\"> </use> </svg> <span class=\"display-inline-flex flex-justify-center flex-1 button-label\"> Cite </span> </button> </li> <li> <button aria-label=\"Save article in MyNCBI collections.\" class=\"usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty\"> <svg aria-hidden=\"true\" class=\"usa-icon width-3 height-3 usa-icon--bookmark-full\" focusable=\"false\" hidden=\"\" role=\"img\"> <use xlink:href=\"/static/img/action-bookmark-full.svg#icon\"> </use> </svg> <svg aria-hidden=\"true\" class=\"usa-icon width-3 height-3 usa-icon--bookmark-empty\" focusable=\"false\" hidden=\"\" role=\"img\"> <use xlink:href=\"/static/img/action-bookmark-empty.svg#icon\"> </use> </svg> <span class=\"display-inline-flex flex-justify-center flex-1\"> Collections </span> </button> </li> <li class=\"pmc-permalink\"> <button aria-expanded=\"false\" aria-haspopup=\"true\" aria-label=\"Show article permalink\" class=\"usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none\" type=\"button\"> <svg aria-hidden=\"true\" class=\"usa-icon width-3 height-3\" focusable=\"false\" hidden=\"\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#share\"> </use> </svg> <span class=\"display-inline-flex flex-justify-center flex-1 button-label\"> Permalink </span> </button> <div class=\"pmc-permalink__dropdown\" hidden=\"\"> <div class=\"pmc-permalink__dropdown__container\"> <h2 class=\"usa-modal__heading margin-top-0 margin-bottom-2\"> PERMALINK </h2> <div class=\"pmc-permalink__dropdown__content\"> <input aria-label=\"Article permalink\" class=\"usa-input\" type=\"text\" value=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC11066909/\"/> <button aria-expanded=\"false\" class=\"usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0\" title=\"Copy article permalink\"> <svg aria-hidden=\"true\" class=\"usa-icon\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#content_copy\"> </use> </svg> <span class=\"margin-left-1\"> Copy </span> </button> </div> </div> </div> </li> </ul> </section> </div> <section class=\"pmc-resources margin-top-6 desktop:margin-top-4\"> <h2 class=\"margin-top-0\"> RESOURCES </h2> <div class=\"usa-accordion usa-accordion--multiselectable\"> <h3 class=\"usa-accordion__heading\"> <button aria-controls=\"resources-similar-articles\" aria-expanded=\"false\" class=\"usa-accordion__button\" type=\"button\"> Similar articles </button> </h3> <div class=\"usa-accordion__content usa-prose\" hidden=\"\" id=\"resources-similar-articles\"> </div> <h3 class=\"usa-accordion__heading\"> <button aria-controls=\"resources-cited-by-other-articles\" aria-expanded=\"false\" class=\"usa-accordion__button\" type=\"button\"> Cited by other articles </button> </h3> <div class=\"usa-accordion__content usa-prose\" hidden=\"\" id=\"resources-cited-by-other-articles\"> </div> <h3 class=\"usa-accordion__heading\"> <button aria-controls=\"resources-links-to-ncbi-databases\" aria-expanded=\"false\" class=\"usa-accordion__button\" type=\"button\"> Links to NCBI Databases </button> </h3> <div class=\"usa-accordion__content usa-prose\" hidden=\"\" id=\"resources-links-to-ncbi-databases\"> </div> </div> </section> <section class=\"usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4\"> <nav aria-label=\"On this page\" class=\"usa-in-page-nav__nav\"> <h2 class=\"usa-in-page-nav__heading\" tabindex=\"0\"> On this page </h2> <ul class=\"usa-in-page-nav__list\"> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#abstract1\"> Abstract </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#s5\"> Methods </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#s20\"> Results </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#s27\"> Discussion </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#sec28\"> Supplementary Material </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#a1\"> Acknowledgments </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#_ci93_\"> Contributor Information </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#s29\"> Conflict of interest statement </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#s30\"> Funding </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#s31\"> Author Contributions </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#r1\"> References </a> </li> <li class=\"usa-in-page-nav__item\"> <a class=\"usa-in-page-nav__link\" href=\"#_ad93_\"> Associated Data </a> </li> </ul> </nav> </section> </section> </div> <div aria-label=\"Citation Dialog\" class=\"overlay citation-dialog-overlay\" role=\"dialog\"> <div aria-hidden=\"true\" class=\"dialog citation-dialog\" role=\"document\"> <div class=\"display-inline-flex flex-align-center flex-justify width-full margin-bottom-2\"> <h2 class=\"usa-modal__heading margin-0\"> Cite </h2> <button class=\"usa-button usa-button--unstyled close-overlay text-black width-auto\" tabindex=\"1\" type=\"button\"> <svg aria-hidden=\"true\" class=\"usa-icon width-3 height-3\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#close\"> </use> </svg> </button> </div> <div class=\"citation-text-block\"> <div class=\"citation-text margin-bottom-2\"> </div> <ul class=\"usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center\"> <li> <button class=\"usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus\" tabindex=\"2\"> <svg aria-hidden=\"true\" class=\"usa-icon width-3 height-3\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#content_copy\"> </use> </svg> <span> Copy </span> </button> </li> <li> <a class=\"usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button\" href=\"#\" role=\"button\" tabindex=\"3\" title=\"Download a file for external citation management software\"> <svg aria-hidden=\"true\" class=\"usa-icon width-3 height-3\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#file_download\"> </use> </svg> <span class=\"display-none mobile-lg:display-inline\"> Download .nbib </span> <span class=\"display-inline mobile-lg:display-none\"> .nbib </span> </a> </li> <li> <div class=\"display-inline-flex flex-align-center\"> <label class=\"usa-label margin-top-0\"> Format: </label> <select aria-label=\"Format\" class=\"usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4\" tabindex=\"4\"> <option value=\"AMA\"> AMA </option> <option value=\"APA\"> APA </option> <option value=\"MLA\"> MLA </option> <option selected=\"selected\" value=\"NLM\"> NLM </option> </select> </div> </li> </ul> <div class=\"dots-loading-indicator citation-loading-indicator\"> <div class=\"dot dot-1\"> </div> <div class=\"dot dot-2\"> </div> <div class=\"dot dot-3\"> </div> </div> </div> </div> </div> <div class=\"overlay collections-dialog-overlay\" role=\"dialog\"> <div aria-hidden=\"true\" class=\"dialog collections-dialog\" id=\"collections-action-dialog\" role=\"document\"> <div class=\"display-inline-flex flex-align-center flex-justify width-full margin-bottom-2\"> <h2 class=\"usa-modal__heading margin-0\"> Add to Collections </h2> </div> <div class=\"collections-action-panel action-panel\"> <form class=\"usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors\" id=\"collections-action-dialog-form\"> <fieldset class=\"usa-fieldset margin-bottom-2\"> <div class=\"usa-radio\"> <input class=\"usa-radio__input usa-radio__input--tile collections-new margin-top-0\" id=\"collections-action-dialog-new\" name=\"collections\" type=\"radio\" value=\"new\"/> <label class=\"usa-radio__label\" for=\"collections-action-dialog-new\"> Create a new collection </label> </div> <div class=\"usa-radio\"> <input checked=\"true\" class=\"usa-radio__input usa-radio__input--tile collections-existing\" id=\"collections-action-dialog-existing\" name=\"collections\" type=\"radio\" value=\"existing\"/> <label class=\"usa-radio__label\" for=\"collections-action-dialog-existing\"> Add to an existing collection </label> </div> </fieldset> <fieldset class=\"usa-fieldset margin-bottom-2\"> <div class=\"action-panel-control-wrap new-collections-controls\"> <label class=\"usa-label margin-top-0\" for=\"collections-action-dialog-add-to-new\"> Name your collection <abbr class=\"usa-hint usa-hint--required text-no-underline\" title=\"required\"> * </abbr> </label> <input class=\"usa-input collections-action-add-to-new\" id=\"collections-action-dialog-add-to-new\" maxlength=\"\" name=\"add-to-new-collection\" pattern='[^\"&amp;=&lt;&gt;/]*' required=\"\" title='The following characters are not allowed in the Name field: \"&amp;=&lt;&gt;/' type=\"text\"/> </div> <div class=\"action-panel-control-wrap existing-collections-controls\"> <label class=\"usa-label margin-top-0\" for=\"collections-action-dialog-add-to-existing\"> Choose a collection </label> <select class=\"usa-select collections-action-add-to-existing\" id=\"collections-action-dialog-add-to-existing\"> </select> <div class=\"collections-retry-load-on-error usa-input-error-message selection-validation-message\"> Unable to load your collection due to an error <br/> <a href=\"#\"> Please try again </a> </div> </div> </fieldset> <div class=\"display-inline-flex\"> <button class=\"usa-button margin-top-0 action-panel-submit\" type=\"submit\"> Add </button> <button aria-label=\"Close 'Add to Collections' panel\" class=\"usa-button usa-button--outline margin-top-0 action-panel-cancel\" ref=\"linksrc=close_collections_panel\"> Cancel </button> </div> </form> </div> </div> </div> </div> </div> </div> <footer class=\"ncbi-footer ncbi-dark-background\"> <div class=\"ncbi-footer__icon-section\"> <div class=\"ncbi-footer__social-header\"> Follow NCBI </div> <div class=\"grid-container ncbi-footer__ncbi-social-icons-container\"> <a class=\"ncbi-footer__social-icon ncbi-footer__social-icon--gray\" href=\"https://twitter.com/ncbi\" rel=\"noreferrer noopener\" target=\"_blank\"> <svg aria-hidden=\"true\" fill=\"none\" focusable=\"false\" height=\"40\" viewbox=\"0 0 40 40\" width=\"40\" xmlns=\"http://www.w3.org/2000/svg\"> <path d=\"m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z\"> </path> </svg> <span class=\"usa-sr-only\"> NCBI on X (formerly known as Twitter) </span> </a> <a class=\"ncbi-footer__social-icon ncbi-footer__social-icon--gray\" href=\"https://www.facebook.com/ncbi.nlm\" rel=\"noreferrer noopener\" target=\"_blank\"> <svg aria-hidden=\"true\" fill=\"none\" focusable=\"false\" height=\"29\" viewbox=\"0 0 16 29\" width=\"16\" xmlns=\"http://www.w3.org/2000/svg\"> <path d=\"M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z\"> </path> </svg> <span class=\"usa-sr-only\"> NCBI on Facebook </span> </a> <a class=\"ncbi-footer__social-icon ncbi-footer__social-icon--gray\" href=\"https://www.linkedin.com/company/ncbinlm\" rel=\"noreferrer noopener\" target=\"_blank\"> <svg aria-hidden=\"true\" fill=\"none\" focusable=\"false\" height=\"23\" viewbox=\"0 0 26 24\" width=\"25\" xmlns=\"http://www.w3.org/2000/svg\"> <path d=\"M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z\"> </path> <path d=\"M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z\"> </path> <path d=\"M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z\"> </path> </svg> <span class=\"usa-sr-only\"> NCBI on LinkedIn </span> </a> <a class=\"ncbi-footer__social-icon ncbi-footer__social-icon--gray\" href=\"https://github.com/ncbi\" rel=\"noreferrer noopener\" target=\"_blank\"> <svg aria-hidden=\"true\" fill=\"none\" focusable=\"false\" height=\"27\" viewbox=\"0 0 28 28\" width=\"28\" xmlns=\"http://www.w3.org/2000/svg\"> <path d=\"M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z\"> </path> </svg> <span class=\"usa-sr-only\"> NCBI on GitHub </span> </a> <a class=\"ncbi-footer__social-icon ncbi-footer__social-icon--gray\" href=\"https://ncbiinsights.ncbi.nlm.nih.gov/\" rel=\"noreferrer noopener\" target=\"_blank\"> <svg aria-hidden=\"true\" fill=\"none\" focusable=\"false\" height=\"26\" viewbox=\"0 0 27 27\" width=\"26\" xmlns=\"http://www.w3.org/2000/svg\"> <path d=\"M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z\"> </path> <path d=\"M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z\"> </path> <path d=\"M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z\"> </path> </svg> <span class=\"usa-sr-only\"> NCBI RSS feed </span> </a> </div> </div> <div class=\"grid-container ncbi-footer__container\"> <div class=\"grid-row ncbi-footer__main-content-container\"> <div class=\"ncbi-footer__column\"> <p class=\"ncbi-footer__circled-icons-heading\"> Connect with NLM </p> <div class=\"ncbi-footer__circled-icons-list\"> <a class=\"ncbi-footer__social-icon ncbi-footer__social-icon--circled\" href=\"https://twitter.com/nlm_nih\" rel=\"noreferrer noopener\" target=\"_blank\"> <svg aria-hidden=\"true\" fill=\"none\" focusable=\"false\" height=\"32\" viewbox=\"0 0 40 40\" width=\"32\" xmlns=\"http://www.w3.org/2000/svg\"> <path d=\"m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z\"> </path> </svg> <span class=\"usa-sr-only\"> NLM on X (formerly known as Twitter) </span> </a> <a class=\"ncbi-footer__social-icon ncbi-footer__social-icon--circled\" href=\"https://www.facebook.com/nationallibraryofmedicine\" rel=\"noreferrer noopener\" target=\"_blank\"> <svg aria-hidden=\"true\" fill=\"none\" focusable=\"false\" height=\"24\" viewbox=\"0 0 13 24\" width=\"13\" xmlns=\"http://www.w3.org/2000/svg\"> <path d=\"M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z\"> </path> </svg> <span class=\"usa-sr-only\"> NLM on Facebook </span> </a> <a class=\"ncbi-footer__social-icon ncbi-footer__social-icon--circled\" href=\"https://www.youtube.com/user/NLMNIH\" rel=\"noreferrer noopener\" target=\"_blank\"> <svg aria-hidden=\"true\" fill=\"none\" focusable=\"false\" height=\"15\" viewbox=\"0 0 21 15\" width=\"21\" xmlns=\"http://www.w3.org/2000/svg\"> <path d=\"M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z\" fill=\"white\"> </path> </svg> <span class=\"usa-sr-only\"> NLM on YouTube </span> </a> </div> </div> <address class=\"ncbi-footer__address ncbi-footer__column\"> <p> <a class=\"usa-link usa-link--external\" href=\"https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508, -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508! 4d-77.0988323\" rel=\"noopener noreferrer\" target=\"_blank\"> National Library of Medicine <br/> 8600 Rockville Pike <br/> Bethesda, MD 20894 </a> </p> </address> <ul class=\"usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column\"> <li class=\"ncbi-footer__vertical-list-item\"> <a class=\"usa-link usa-link--alt ncbi-footer__link\" href=\"https://www.nlm.nih.gov/web_policies.html\"> Web Policies </a> </li> <li class=\"ncbi-footer__vertical-list-item\"> <a class=\"usa-link usa-link--alt ncbi-footer__link\" href=\"https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office\"> FOIA </a> </li> <li class=\"ncbi-footer__vertical-list-item\"> <a class=\"usa-link usa-link--external usa-link--alt ncbi-footer__link\" href=\"https://www.hhs.gov/vulnerability-disclosure-policy/index.html\" rel=\"noreferrer noopener\" target=\"_blank\"> HHS Vulnerability Disclosure </a> </li> </ul> <ul class=\"usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column\"> <li class=\"ncbi-footer__vertical-list-item\"> <a class=\"usa-link usa-link--alt ncbi-footer__link\" href=\"https://support.nlm.nih.gov/?pagename=cloudpmc-viewer%3Apmc%3Aarticle%3Ajournal\"> Help </a> </li> <li class=\"ncbi-footer__vertical-list-item\"> <a class=\"usa-link usa-link--alt ncbi-footer__link\" href=\"https://www.nlm.nih.gov/accessibility.html\"> Accessibility </a> </li> <li class=\"ncbi-footer__vertical-list-item\"> <a class=\"usa-link usa-link--alt ncbi-footer__link\" href=\"https://www.nlm.nih.gov/careers/careers.html\"> Careers </a> </li> </ul> </div> <div class=\"grid-row grid-col-12\"> <ul class=\"ncbi-footer__bottom-links-list\"> <li class=\"ncbi-footer__bottom-list-item\"> <a class=\"usa-link usa-link--alt ncbi-footer__link\" href=\"https://www.nlm.nih.gov/\"> NLM </a> </li> <li class=\"ncbi-footer__bottom-list-item\"> <a class=\"usa-link usa-link--alt ncbi-footer__link\" href=\"https://www.nih.gov/\"> NIH </a> </li> <li class=\"ncbi-footer__bottom-list-item\"> <a class=\"usa-link usa-link--external usa-link--alt ncbi-footer__link\" href=\"https://www.hhs.gov/\" rel=\"noreferrer noopener\" target=\"_blank\"> HHS </a> </li> <li class=\"ncbi-footer__bottom-list-item\"> <a class=\"usa-link usa-link--external usa-link--alt ncbi-footer__link\" href=\"https://www.usa.gov/\" rel=\"noreferrer noopener\" target=\"_blank\"> USA.gov </a> </li> </ul> </div> </div> </footer> <div id=\"ZN_dikYWqsjiUWN0Q5\"> </div> <button class=\"back-to-top\"> <label> Back to Top </label> <svg aria-hidden=\"true\" class=\"usa-icon order-0\" focusable=\"false\" role=\"img\"> <use xlink:href=\"/static/img/sprite.svg#arrow_upward\"> </use> </svg> </button> <div class=\"fake-body-scroll\"> </div> <div class=\"fake-body-scroll\"> </div> <div class=\"QSIFeedbackButton\"> <button aria-label=\"Tell us what you think!\" id=\"QSIFeedbackButton-btn\" role=\"button\"> <img alt=\"Tell us what you think!\" src=\"https://iad1.qualtrics.com/WRQualtricsSiteIntercept/Graphic.php?IM=IM_3xWqwNkIHc7cA0S\"/> </button> </div> </body> </html>) and a list of known data repositories (bigd.big.ac.cn, massive.ucsd.edu, www.ebi.ac.uk, www.iprox.cn, proteomecentral.proteomexchange.org, www.proteomexchange.org, pdc.cancer.gov, doi.org, www.ncbi.nlm.nih.gov). Given this information, please return a JSON array of objects where each object has the following structure:\n- `dataset_identifier`: The dataset identifier (a code). If not found, set it to \"n/a\".\n- `repository_reference`: The URL or reference to the data repository. If not found, set it to \"n/a\".\n\nPlease follow these strict instructions:\n- The output must be a valid JSON array of objects.\n- Each object must contain the keys `dataset_identifier` and `repository_reference`.\n- Any other output format will be considered invalid."}]}]